<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>PMC</source>
  <date>20140719</date>
  <key>pmc.key</key>
  <document>
    <id>PMC4967944</id>
    <passage>
      <infon key="name_2">surname:Pich;given-names:Christine</infon>
      <infon key="name_3">surname:Ibberson;given-names:Mark</infon>
      <infon key="name_0">surname:Degueurce;given-names:Gwendoline</infon>
      <infon key="name_1">surname:D'Errico;given-names:Ilenia</infon>
      <infon key="name_6">surname:Sgandurra;given-names:Marie</infon>
      <infon key="alt-title">Gwendoline Degueurce et&#160;al</infon>
      <infon key="article-id_publisher-id">EMMM201505384</infon>
      <infon key="name_5">surname:Montagner;given-names:Alexandra</infon>
      <infon key="name_8">surname:Jafari;given-names:Paris</infon>
      <infon key="name_9">surname:Boda;given-names:Akash</infon>
      <infon key="lpage">936 936</infon>
      <infon key="fpage">919 919</infon>
      <infon key="year">2016</infon>
      <infon key="kwd">inflammation miRNA PPAR&#946;/&#948; skin therapeutics Immunology Pharmacology &amp; Drug Discovery</infon>
      <infon key="name_4">surname:Sch&#252;tz;given-names:Fr&#233;d&#233;ric</infon>
      <infon key="title">Subject Categories</infon>
      <infon key="article-id_doi">10.15252/emmm.201505384</infon>
      <infon key="article-id_pmid">27250636</infon>
      <infon key="name_7">surname:Mury;given-names:Lionel</infon>
      <infon key="source">EMBO Mol Med</infon>
      <infon key="issue">8</infon>
      <infon key="volume">8 8</infon>
      <infon key="article-id_pmc">4967944</infon>
      <infon key="license">This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="type">front</infon>
      <infon key="notes">

 () : &#8211;

</infon>
      <infon key="name_10">surname:Meunier;given-names:Julien</infon>
      <infon key="name_11">surname:Rezzonico;given-names:Roger</infon>
      <infon key="name_12">surname:Brembilla;given-names:Nicol&#242; Costantino</infon>
      <infon key="name_13">surname:Hohl;given-names:Daniel</infon>
      <infon key="name_14">surname:Kolios;given-names:Antonios</infon>
      <infon key="name_15">surname:Hofbauer;given-names:G&#252;nther</infon>
      <infon key="name_16">surname:Xenarios;given-names:Ioannis</infon>
      <infon key="name_17">surname:Michalik;given-names:Liliane</infon>
      <offset>0</offset>
      <text>Identification of a novel PPAR&#946;/&#948;/miR&#8208;21&#8208;3p axis in UV&#8208;induced skin inflammation</text>
    </passage>
    <passage>
      <infon key="type">abstract_title_1</infon>
      <offset>89</offset>
      <text>Abstract</text>
    </passage>
    <passage>
      <infon key="type">abstract</infon>
      <offset>98</offset>
      <text>Although excessive exposure to UV is widely recognized as a major factor leading to skin perturbations and cancer, the complex mechanisms underlying inflammatory skin disorders resulting from UV exposure remain incompletely characterized. The nuclear hormone receptor PPAR&#946;/&#948; is known to control mouse cutaneous repair and UV&#8208;induced skin cancer development. Here, we describe a novel PPAR&#946;/&#948;&#8208;dependent molecular cascade involving TGF&#946;1 and miR&#8208;21&#8208;3p, which is activated in the epidermis in response to UV exposure. We establish that the passenger miRNA miR&#8208;21&#8208;3p, that we identify as a novel UV&#8208;induced miRNA in the epidermis, plays a pro&#8208;inflammatory function in keratinocytes and that its high level of expression in human skin is associated with psoriasis and squamous cell carcinomas. Finally, we provide evidence that inhibition of miR&#8208;21&#8208;3p reduces UV&#8208;induced cutaneous inflammation in ex&#160;vivo human skin biopsies, thereby underlining the clinical relevance of miRNA&#8208;based topical therapies for cutaneous disorders.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>1151</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>1164</offset>
      <text>Skin disorders accompanied by acute or chronic inflammation are the most common dermatological pathologies. They may be associated with genetic traits (Ellinghaus et&#160;al, 2013) or environmental factors, such as invading microbial pathogens or solar ultraviolet radiation (UV) (Matsumura &amp; Ananthaswamy, 2004). Although natural sunlight or UV exposure has beneficial aspects&#8212;for example, vitamin D production or improved dermatoses (Holick, 2008; Kochevar et&#160;al, 2008)&#8212;excessive exposure to UV is widely recognized as a major factor leading to skin perturbations (Kochevar et&#160;al, 2008). The skin's response to UV exposure includes inflammation, disruption of the epidermal barrier function, premature aging, and ultimately, UV&#8208;induced carcinogenesis (Holleran et&#160;al, 1997; Baumann, 2007; Narayanan et&#160;al, 2010; Biniek et&#160;al, 2012). Therefore, it is important to further understand the complex and incompletely characterized mechanisms underlying inflammatory skin disorders resulting from UV exposure.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>2176</offset>
      <text>The nuclear hormone receptor peroxisome proliferator&#8208;activated receptor &#946;/&#948; (PPAR&#946;/&#948;)&#8212;the prevalent PPAR subtype in human and murine epidermis&#8212;is an important player in the maintenance of skin homeostasis. It regulates keratinocyte differentiation and lipid synthesis, restores epidermal barrier function following a mechanical disruption, and attenuates UVB&#8208;induced senescence in keratinocytes (Michalik &amp; Wahli, 2007; Pal et&#160;al, 2011; Sertznig &amp; Reichrath, 2011; Ham et&#160;al, 2012). Upon skin injury, PPAR&#946;/&#948; activation promotes skin healing through activation of keratinocyte proliferation, survival, and migration (Michalik et&#160;al, 2001; Tan et&#160;al, 2001, 2005). In contrast to these beneficial functions, we recently showed that epidermal activation of PPAR&#946;/&#948; also favored the progression of UV&#8208;induced skin squamous cell carcinoma (Montagner et&#160;al, 2013). The outcome of PPAR&#946;/&#948; activity essentially relies on transcriptional activation of target genes, but also on less frequent indirect repressive effects (Feige et&#160;al, 2006). Although PPARs were recently reported to regulate the expression of a few miRNAs (Shah et&#160;al, 2007; Yin et&#160;al, 2010; Gan et&#160;al, 2013; Song et&#160;al, 2013; Panza et&#160;al, 2014; Yu et&#160;al, 2014; Dharap et&#160;al, 2015), the underlying mechanisms and outcomes are poorly understood.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>3513</offset>
      <text>The role of miRNAs in the skin was first demonstrated by the conditional inactivation of the small RNA&#8208;processing pathway in keratinocytes, which resulted in striking defects in skin morphogenesis (Andl et&#160;al, 2006; Yi et&#160;al, 2006, 2009). Since then, miRNAs&#8212;among them the oncomiR miR&#8208;21&#8208;5p, one of the most studied miRNAs&#8212;have been shown to be implicated in the regulation of skin homeostasis (Yi et&#160;al, 2006, 2008), skin repair (Banerjee et&#160;al, 2011; Yang et&#160;al, 2011 ; Pastar et&#160;al, 2012; Li et&#160;al, 2015), and skin disorders such as psoriasis (Joyce et&#160;al, 2011; Xia &amp; Zhang, 2014; Hawkes et&#160;al, 2016) and squamous cell carcinomas (Medina et&#160;al, 2010; Darido et&#160;al, 2011; Lefort et&#160;al, 2013; Gastaldi et&#160;al, 2014). Recent studies indicate that miRNAs are affected by UV exposure in various isolated cell types (Guo et&#160;al, 2009; Pothof et&#160;al, 2009; Dziunycz et&#160;al, 2010; Hou et&#160;al, 2013), but their functions in the skin response to UV still remain to be characterized.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>4512</offset>
      <text>Here, we identify miR&#8208;21&#8208;3p as a UV&#8208; and PPAR&#946;/&#948;&#8208;activated pro&#8208;inflammatory miRNA in keratinocytes in culture and in&#160;vivo, and we propose that topical inhibition of miR&#8208;21&#8208;3p is of therapeutic interest in human inflammatory skin disorders.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>4769</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>4777</offset>
      <text>miR&#8208;21&#8208;3p is an epidermal, UV&#8208;induced, PPAR&#946;/&#948;&#8208;activated miRNA</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>4850</offset>
      <text>We recently demonstrated that Ppard+/+ mice chronically exposed to ultraviolet radiation (UV) displayed earlier skin lesions and faster progression of UV&#8208;induced skin carcinogenesis compared to Ppard&#8722;/&#8722; animals (Montagner et&#160;al, 2013). In order to identify PPAR&#946;/&#948;&#8208;regulated&#160;miRNA involved in the skin response to UV, we compared miRNA expression in skin samples harvested from Ppard+/+ and Ppard&#8722;/&#8722; mice non&#8208;irradiated (control), or following acute (24&#160;h after a single dose of UV) or chronic UV exposure (12&#160;weeks of repeated UV exposure; non&#8208;lesional skin). This comparative study highlighted 12 major miRNAs, whose expression was affected (&#8805;&#160;1.5&#8208;fold) in a PPAR&#946;/&#948;&#8208;dependent manner, among which nine were overexpressed, while the remaining three showed&#160;lower levels in Ppard+/+ compared to Ppard&#8722;/&#8722; skin (Appendix&#160;Table&#160;S1). Among the miRNAs whose expression was upregulated by UV exposure in Ppard+/+ skin, miR&#8208;21&#8208;3p particularly attracted our attention as it is the passenger miRNA of the guide miR&#8208;21&#8208;5p (commonly named miR&#8208;21). MiR&#8208;21&#8208;5p is a well&#8208;characterized &#8220;oncomiR&#8221; induced by UV irradiation (Guo et&#160;al, 2009; Hou et&#160;al, 2013) and known for its oncogenic role in skin squamous cell carcinomas (Darido et&#160;al, 2011; Xu et&#160;al, 2012; Bruegger et&#160;al, 2013). Although passenger miRNAs are commonly thought to be degraded upon miRNA processing, here we confirmed miR&#8208;21&#8208;3p expression by quantifying RNA sequencing counts in various murine organs, including the skin (Meunier et&#160;al, 2013). The increased miR&#8208;21&#8208;3p/miR&#8208;21&#8208;5p ratio in the skin compared to other organs (Appendix&#160;Fig S1A) was not due to a lower expression in miR&#8208;21&#8208;5p, but to enrichment in miR&#8208;21&#8208;3p expression in that organ (Fig&#160;1A). In situ hybridization performed in Ppard+/+ skin revealed that miR&#8208;21&#8208;3p was expressed in the epidermis and hair follicles, with little or no expression in the dermis (Fig&#160;1B, top left panel). Following acute UV exposure, miR&#8208;21&#8208;3p level was strongly increased in Ppard+/+ epidermis, while remaining below detection levels in the dermis (Fig&#160;1B, bottom left panel). We confirmed and quantified the epidermal increase of miR&#8208;21&#8208;3p expression following UV exposure using RT&#8211;qPCR (Fig&#160;1C) and RNA sequencing (Appendix&#160;Fig S1B) of isolated epidermis and dermis samples, whose successful separation was confirmed using specific markers (Appendix&#160;Fig S1C). Notably, in&#160;vivo miR&#8208;21&#8208;3p localization and expression compare with those of PPAR&#946;/&#948; mRNA, also upregulated in the epidermis upon UV exposure (Appendix&#160;Fig S1D).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>7482</offset>
      <text> PPAR&#946;/&#948; activates the expression of UV&#8208;induced epidermal miR&#8208;21&#8208;3p</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7558</offset>
      <text>RT&#8211;qPCR quantification of relative miR&#8208;21&#8208;3p and miR&#8208;21&#8208;5p levels in mouse brain, heart, kidney, and epidermis. N&#160;=&#160;4 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>7783</offset>
      <text>Fluorescent miR&#8208;21&#8208;3p in&#160;situ hybridization (pink) in dorsal skin of acutely irradiated (Ac&#8208;UV) and non&#8208;irradiated (no UV) Ppard+/+ and Ppard&#8722;/&#8722; mice. E: epidermis; D:&#160;dermis; HF: hair follicle. Scale bar: 100&#160;&#956;m.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>8013</offset>
      <text>RT&#8211;qPCR quantification of relative pri&#8208;miR&#8208;21 and miR&#8208;21&#8208;3p levels in the epidermis (left and middle) and of relative miR&#8208;21&#8208;3p level in the dermis (right) of acutely irradiated (Ac&#8208;UV; +) and non&#8208;irradiated (&#8722;) Ppard+/+ and Ppard&#8722;/&#8722; mice. Pri&#8208;miR&#8208;21: Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.022; miR&#8208;21&#8208;3p: Ppard+/+ no UV vs. Ppard+/+ Ac&#8208;UV P&#160;=&#160;0.017, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.008. N&#160;=&#160;3&#8211;4 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>8574</offset>
      <text>RT&#8211;qPCR quantification of relative miR&#8208;21&#8208;3p levels in total skin of chronically irradiated (Chr&#8208;UV; +) and non&#8208;irradiated (&#8722;) Ppard+/+ and Ppard&#8722;/&#8722; mice. miR&#8208;21&#8208;3p: Ppard+/+ no UV vs. Ppard+/+ Chr&#8208;UV P&#160;=&#160;0.008, Ppard+/+ Chr&#8208;UV vs. Ppard&#8722;/&#8722; Chr&#8208;UV P&#160;=&#160;0.002, ns: non&#8208;significant. N&#160;=&#160;4 animals per groups, one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>8992</offset>
      <text>RT&#8211;qPCR quantification of relative miR&#8208;21&#8208;3p level in the epidermis of Ppard+/+ and Ppard&#8722;/&#8722; mice, acutely irradiated (Ac&#8208;UV; +) or non&#8208;irradiated (&#8722;), treated with the PPAR&#946;/&#948; antagonist GSK0660 (+) or vehicle (&#8722;), as indicated. miR&#8208;21&#8208;3p: Ppard+/+ no UV vs. Ppard+/+ Ac&#8208;UV P&#160;=&#160;0.005, Ppard+/+ Ac&#8208;UV vs. Ppard+/+ Ac&#8208;UV/GSK0660 P&#160;=&#160;0.04, N&#160;=&#160;5 (Ppard+/+) to 3 (Ppard&#8722;/&#8722;) animals per group. One representative experiment is shown out of two independent replicates</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>9495</offset>
      <text>RT&#8211;qPCR quantification of relative miR&#8208;21&#8208;3p levels in HaCat cells treated with the PPAR&#946;/&#948; agonists GW501516, GW0742 (+), or vehicle (&#8722;) as indicated. miR&#8208;21&#8208;3p: Veh vs. GW501516 P&#160;=&#160;4E&#8208;04, Veh vs. GW0742 P&#160;=&#160;2E&#8208;04. N&#160;=&#160;2&#8211;3 biological replicates, one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>9843</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>10023</offset>
      <text>PPAR&#946;/&#948;&#8208;dependent upregulation of miR&#8208;21&#8208;3p was then demonstrated in models of genetic and pharmacological modulation of PPAR&#946;/&#948; function. In situ hybridization and RT&#8211;PCR quantification revealed that while miR&#8208;21&#8208;3p level was upregulated in Ppard+/+ skin samples in response to acute and chronic UV exposure, it remained expressed at its basal level in the skin of Ppard&#8722;/&#8722; animals (Fig&#160;1B&#8211;D). Moreover, in&#160;vivo topical inhibition of PPAR&#946;/&#948; with an antagonist significantly reduced the magnitude of miR&#8208;21&#8208;3p UV&#8208;dependent increase in the epidermis of Ppard+/+ mice, but did not affect miR&#8208;21&#8208;3p expression in the epidermis of Ppard&#8722;/&#8722; mice (Fig&#160;1E). Finally, the upregulation of the human miR&#8208;21&#8208;3p by PPAR&#946;/&#948; was also confirmed in the human keratinocytes HaCaT following activation of PPAR&#946;/&#948; with its two agonists GW501516 and GW0742 (Fig&#160;1F), like the two well&#8208;characterized PPAR&#946;/&#948; target genes Angptl4 and Tgfb1 (Appendix&#160;Fig S1E).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>11017</offset>
      <text>Collectively, these findings establish that the passenger miRNA miR&#8208;21&#8208;3p is selectively expressed in the epidermis where it is strongly upregulated in response to UV exposure and that PPAR&#946;/&#948; is an activator of both murine and human miR&#8208;21&#8208;3p.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>11272</offset>
      <text>PPAR&#946;/&#948; activates miR&#8208;21&#8208;3p expression indirectly via TGF&#946;1</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>11342</offset>
      <text>The gene encoding miR&#8208;21&#8208;3p and miR&#8208;21&#8208;5p (MIR21) is transcribed into the primary transcript pri&#8208;miR&#8208;21, which is further processed into pre&#8208;miR&#8208;21. Pre&#8208;miRNA is in turn processed into a duplex consisting of the passenger miR&#8208;21&#8208;3p and the guide miR&#8208;21&#8208;5p by the Dicer complex (Mah et&#160;al, 2010; Kumarswamy et&#160;al, 2011). UV&#8208;induced expression of pri&#8208;miR&#8208;21 was partially but significantly reduced in Ppard&#8722;/&#8722; compared to Ppard+/+ epidermis (Fig&#160;1C, left panel), and activation of PPAR&#946;/&#948; with its agonist GW0742 resulted in an increase of pri&#8208;miR&#8208;21 expression in human keratinocytes (Fig&#160;2A), suggesting a transcriptional regulation of the miR&#8208;21&#8208;5p/miR&#8208;21&#8208;3p&#8208;encoding gene by PPAR&#946;/&#948;. However, in silico analyses did not reveal any PPAR binding site (PPAR response elements, direct repeats of DR1 type) in the promoter of MIR21 (Ribas et&#160;al, 2012). Furthermore, the inhibition of protein synthesis with cycloheximide completely prevented PPAR&#946;/&#948;&#8208;dependent upregulation of pri&#8208;miR&#8208;21 in human keratinocytes (Fig&#160;2A). These data suggest that PPAR&#946;/&#948; activates the transcription of the miR&#8208;21&#8208;5p/miR&#8208;21&#8208;3p encoding gene in an indirect fashion.</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>12562</offset>
      <text>Activation of miR&#8208;21&#8208;3p by PPAR&#946;/&#948; requires activation of the TGF&#946; receptor</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>12648</offset>
      <text>RT&#8211;qPCR quantification of relative pri&#8208;miR&#8208;21 level in HaCaT human keratinocytes treated with the PPAR&#946;/&#948; agonist GW0742 (+) or vehicle (&#8722;), with (+) or without (&#8722;) cycloheximide (Cyclo) as indicated. Pri&#8208;miR&#8208;21: Veh vs. GW0742 P&#160;=&#160;0.009. N&#160;=&#160;3 biological replicates, one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>13010</offset>
      <text>RT&#8211;qPCR quantification of relative pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, miR&#8208;21&#8208;5p, and miR&#8208;21&#8208;3p levels in HaCaT cells treated for 24&#160;h with 2 or 5&#160;ng/ml of recombinant human TGF&#946;1 (+) or vehicle (&#8722;) as indicated. Pri&#8208;miR&#8208;21: Veh vs. TGF&#946;1 5&#160;ng/ml P&#160;=&#160;0.029; Pre&#8208;miR&#8208;21: Veh vs. TGF&#946;1 5&#160;ng/ml P&#160;=&#160;0.001; miR&#8208;21&#8208;5p: Veh vs. TGF&#946;1 5&#160;ng/ml P&#160;=&#160;0.002; miR&#8208;21&#8208;3p: Veh vs. TGF&#946;1 5&#160;ng/ml P&#160;=&#160;1.7E&#8208;05. N&#160;=&#160;3 biological replicates, one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>13553</offset>
      <text>RT&#8211;qPCR quantification of pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, miR&#8208;21&#8208;5p, and miR&#8208;21&#8208;3p levels in HaCat cells treated for 24&#160;h with the PPAR&#946;/&#948; agonist GW0742 (+), TGF&#946; receptor inhibitor SB431542 (+), or vehicle (&#8722;) as indicated. Pri&#8208;miR&#8208;21: GW0742 vs. SB431542 P&#160;=&#160;0.004, GW0742 vs. GW0742/SB431542 P&#160;=&#160;0.015; Pre&#8208;miR&#8208;21: Veh vs. GW0742 P&#160;=&#160;0.022, GW0742 vs. SB431542 P&#160;=&#160;0.036, GW0742 vs. GW0742/SB431542 P&#160;=&#160;0.024; miR&#8208;21&#8208;5p: GW0742 vs. SB431542 P&#160;=&#160;0.034, GW0742 vs. GW0742/SB431542 P&#160;=&#160;0.024; miR&#8208;21&#8208;3p: Veh vs. GW0742 P&#160;=&#160;0.036, GW0742 vs. SB431542 P&#160;=&#160;0.011, GW0742 vs. GW0742/SB431542 P&#160;=&#160;0.008. N&#160;=&#160;3 biological replicates, one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>14310</offset>
      <text>RT&#8211;qPCR quantification of relative Tgfb1 level in the epidermis of acutely irradiated (Ac&#8208;UV; +) and non&#8208;irradiated (&#8722;) Ppard+/+ and Ppard&#8722;/&#8722; mice. Tfgb1: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;0.034, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.030. N&#160;=&#160;2&#8211;3 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>14679</offset>
      <text>RT&#8211;qPCR quantification of relative miR&#8208;21&#8208;5p and miR&#8208;21&#8208;3p levels in the skin of Ppard+/+ mice treated with the TGF&#946; receptor inhibitor SB431542 (+) or vehicle (&#8722;), with (+) or without (&#8722;) acute UV exposure (Ac&#8208;UV). miR&#8208;21&#8208;5p: no UV vs. Ac&#8208;UV P&#160;=&#160;0.038, Ac&#8208;UV vs. Ac&#8208;UV/SB431542 P&#160;=&#160;0.028; miR&#8208;21&#8208;3p: no UV vs. Ac&#8208;UV P&#160;=&#160;0.017; Ac&#8208;UV vs. Ac&#8208;UV/SB431542 P&#160;=&#160;0.035. N&#160;=&#160;3 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>15191</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>15371</offset>
      <text>Tgfb1 is a well&#8208;characterized PPAR&#946;/&#948; direct target gene (Kim et&#160;al, 2008; Montagner et&#160;al, 2013), and TGF&#946;1 signaling was shown to activate the transcription of miR&#8208;21&#8208;5p in kidney cells (Godwin et&#160;al, 2010; Zhong et&#160;al, 2011). Thus, we addressed the hypothesis that PPAR&#946;/&#948; indirectly upregulated the expression of the miR&#8208;21&#8208;3p/miR&#8208;21&#8208;5p encoding gene through activation of its direct target gene Tgfb1. We first showed that pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, miR&#8208;21&#8208;3p, and miR&#8208;21&#8208;5p were upregulated by TGF&#946;1 in human keratinocytes (Fig&#160;2B), using the TGF&#946;1 target gene SERPINE1 as a positive control (Appendix&#160;Fig S1F). To test whether the transcriptional regulation of the miR&#8208;21&#8208;3p/miR&#8208;21&#8208;5p encoding gene by PPAR&#946;/&#948; was TGF&#946;1 dependent, we combined PPAR&#946;/&#948; activation (GW0742) with TGF&#946; receptor inhibition (SB431542) in human keratinocytes and monitored the expression of ANGPTL4 and SERPINE1&#8212;PPAR&#946;/&#948; and TGF&#946;1 respective target genes&#8212;as controls for treatment efficiency (Appendix&#160;Fig S1G). PPAR&#946;/&#948; activation with its agonist resulted in upregulation of pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, and miR&#8208;21&#8208;3p (Fig&#160;2C), which was prevented by the inhibition of the TGF&#946; receptor. While miR&#8208;21&#8208;5p level was downregulated by TGF&#946; receptor inhibition, it was not significantly affected by PPAR&#946;/&#948; activation (Fig&#160;2C).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>16758</offset>
      <text>We next addressed whether the PPAR&#946;/&#948;&#8208;dependent, UV&#8208;induced upregulation of miR&#8208;21&#8208;3p observed in murine skin in&#160;vivo also required TGF&#946; receptor activity. Mice were exposed to a single dose of UV, with or without cutaneous topical application of the TGF&#946; receptor inhibitor. As expected for a direct PPAR&#946;/&#948; target gene, we confirmed that Tgfb1 expression was increased by acute UV exposure in Ppard+/+ but not in Ppard&#8722;/&#8722; epidermis (Fig&#160;2D; Montagner et&#160;al, 2013). The expression levels of miR&#8208;21&#8208;3p and miR&#8208;21&#8208;5p were upregulated by UV in Ppard+/+ epidermis, an activation that was abolished by topical inhibition of the TGF&#946; receptor (Fig&#160;2E), as also observed for the TGF&#946;1 target gene SERPINE1 used as a positive control (Appendix&#160;Fig S1H).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>17538</offset>
      <text>Interestingly, in silico analyses to generate a list of predicted miR&#8208;21&#8208;3p target mRNA using Diana&#8208;MicroT&#8208;CDS miRNA database (Reczko et&#160;al, 2012; Paraskevopoulou et&#160;al, 2013) revealed SMAD7 as a putative direct target of miR&#8208;21&#8208;3p (by Hits&#8208;Clips, according to Tarbase v7.0 (Vergoulis et&#160;al, 2012)). Among the predicted miR&#8208;21&#8208;3p targets (Appendix&#160;Table&#160;S2), SMAD7 was of particular interest as it acts as an antagonist of TGF&#946;1 signaling (Nakao et&#160;al, 1997; Yan et&#160;al, 2015) and its expression is activated by UV in both murine and human skin (Fig&#160;3A; Quan et&#160;al, 2001). In silico sequence analysis using miRmap interface (Vejnar et&#160;al, 2013) predicted two miR&#8208;21&#8208;3p binding sites in the human SMAD7 3&#8242;UTR, consisting, respectively, of seven and six perfect nucleotide matches (Fig&#160;3B, left). The sequences of both binding sites are 100% conserved between human and mouse. Luciferase reporter assays using the 3&#8242;UTR of SMAD7 demonstrated that miR&#8208;21&#8208;3p mimic delivery significantly reduced the activity of the wild&#8208;type SMAD7 3&#8242;UTR reporter (44%), but not that of the miR&#8208;21&#8208;3p binding site mutant reporter (Fig&#160;3B). miR&#8208;21&#8208;3p mimic delivery to human keratinocytes did not affect endogenous SMAD7 mRNA expression (Fig&#160;3C, left panel), but decreased SMAD7 protein level by 50% (Fig&#160;3C, middle and right panels). Together, these data indicate that SMAD7 is a direct target of miR&#8208;21&#8208;3p regulated at the translational level. However, expression of miR&#8208;21&#8208;3p (Fig&#160;1C) and Smad7 (Fig&#160;3D) was not anti&#8208;correlated in the epidermis of Ppar&#946;+/+ and Ppar&#946;&#8722;/&#8722; mice exposed to UV, indicating that although miR&#8208;21&#8208;3p likely contributes to its regulation, mouse Smad7 level is under unsurprising more complex regulation in&#160;vivo. Of note, miR&#8208;21&#8208;3p may enhance TGF&#946;1 signaling via downregulation of SMAD7. Consistent with this hypothesis, the TGF&#946;1 targets SERPINE, p21 and RUNX were expressed at a higher level, while the expression levels of TGFB1 and its target SNAI2 were not significantly affected, in miR&#8208;21&#8208;3p mimic&#8208;overexpressing HaCat cells following TGF&#946;1 treatment (Fig&#160;3E).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>19704</offset>
      <text> SMAD7 is a target for miR&#8208;21&#8208;3p</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>19741</offset>
      <text>RT&#8211;qPCR quantification of relative SMAD7 expression level in the epidermis of acutely irradiated (Ac&#8208;UV; +) ex&#160;vivo biopsies of human normal skin. SMAD7: no UV vs. Ac&#8208;UV P&#160;=&#160;0.032. N&#160;=&#160;4 biological replicates, one representative experiment is shown out of three independent experiments performed with the skin of three different donors.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>20089</offset>
      <text>Left panel: wild&#8208;type (WT SMAD7 3&#8242;UTR) and mutated (MUT SMAD7 3&#8242;UTR; *: mutated nucleotides) miR&#8208;21&#8208;3p binding sequences in the human SMAD7 3&#8242;UTR. Right panel: Luciferase reporter assay with wild&#8208;type (WT SMAD7 3&#8242;UTR) or mutated (MUT SMAD7 3&#8242;UTR) SMAD7 3&#8242;UTR in HEK 293 cells overexpressing miR&#8208;21&#8208;3p (miR&#8208;21&#8208;3p mimic) or a scrambled sequence (Control).</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>20471</offset>
      <text>Left panel: normalized expression data of SMAD7 mRNA obtained from genomic microarray analysis of human HaCaT cells treated with a miR&#8208;21&#8208;3p mimic (miR&#8208;21&#8208;3p mimic) or a scrambled sequence (control). N&#160;=&#160;3 biological replicates. Middle panel: Western blot quantification of SMAD7 protein level (normalized to GAPDH protein level) in human HaCaT cells treated with a miR&#8208;21&#8208;3p mimic (miR&#8208;21&#8208;3p mimic) or a scrambled sequence (control). SMAD7 protein: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.031. N&#160;=&#160;3 biological replicates. Right panel: Western blot of SMAD7 and GAPDH proteins in human HaCaT cells treated with a miR&#8208;21&#8208;3p mimic (miR&#8208;21&#8208;3p mimic) or a scrambled sequence (control), N&#160;=&#160;3 biological replicates; one representative experiment is shown out of two independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>21287</offset>
      <text>Western blot of Smad7 from epidermis of acutely irradiated (Ac&#8208;UV; +) Ppard+/+ and Ppard&#8722;/&#8722; mice. Loading control: GAPDH.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>21415</offset>
      <text>RT&#8211;qPCR quantification of relative TGFB1, SERPINE1, p21, RUNX, and SNAI2 levels in human HaCaT cells treated with a miR&#8208;21&#8208;3p mimic (miR&#8208;21&#8208;3p mimic) or a scrambled sequence (control) with (+) or without (&#8722;) treatment with 2&#160;ng/ml recombinant TGF&#946;1. SERPINE1: TGF&#946;1 2&#160;ng/ml control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.004; p21: TGF&#946;1 2&#160;ng/ml control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.03; RUNX: TGF&#946;1 2&#160;ng/ml control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.04. N&#160;=&#160;3 biological replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>21912</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>22092</offset>
      <text>Taken together, these results suggest that PPAR&#946;/&#948; indirectly activates the transcription of the gene encoding miR&#8208;21&#8208;3p likely through increased expression of TGF&#946;1 and activation of TGF&#946; receptor. By preventing excessive SMAD7 protein upregulation, miR&#8208;21&#8208;3p may maintain its own expression by activating TGF&#946; signaling.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>22431</offset>
      <text>MiR&#8208;21&#8208;3p is a pro&#8208;inflammatory miRNA in keratinocytes</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>22492</offset>
      <text>To investigate the role of miR&#8208;21&#8208;3p, we mimicked UV&#8208;induced miR&#8208;21&#8208;3p upregulation by transfecting human keratinocytes with a miR&#8208;21&#8208;3p mimic oligonucleotide sequence, using a scrambled sequence as a control (Appendix&#160;Fig S2A). The global impact of miR&#8208;21&#8208;3p gain of function on keratinocyte mRNA expression was investigated by microarray profiling. This analysis revealed that of all the mRNA which expression was affected by miR&#8208;21&#8208;3p mimic transfection, 33% were associated with inflammatory and immune processes (Fig&#160;4A); the four most affected biological processes were immune response, defense response, response to wounding, and inflammatory response (Fig&#160;4B). Among the pro&#8208;inflammatory mediators whose level was affected by miR&#8208;21&#8208;3p in human keratinocytes, we confirmed a strong RNA upregulation of the pro&#8208;inflammatory cytokines IL&#8208;6 and IL&#8208;1B, of the IL&#8208;1 receptor co&#8208;factor IL&#8208;1RAP, of the prostanoid&#8208;producing enzyme cyclooxygenase&#8208;2 (PTGS2), and of the chemokines CCL5 and CXCL10 (Fig&#160;4C). Interestingly, the expression of caspase&#8208;14 (CASP14), whose downregulation was shown following UV&#8208;mediated epidermal barrier disruption, was significantly reduced upon miR&#8208;21&#8208;3p gain of function (Fig&#160;4C).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>23760</offset>
      <text>Gain of miR&#8208;21&#8208;3p function activates inflammation in HaCaT human keratinocytes</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>23843</offset>
      <text>Proportion of inflammatory&#8208; and immune processes&#8208;associated mRNA in regard to the total number of significantly deregulated mRNA in miR&#8208;21&#8208;3p mimic versus scrambled control&#8208;treated HaCaT cells.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24047</offset>
      <text>GO term enrichment analysis based on the significantly upregulated and downregulated mRNA in miR&#8208;21&#8208;3p mimic&#8208;treated compared to scramble control&#8208;treated HaCaT cells.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24222</offset>
      <text>RT&#8211;qPCR analysis of IL6, IL1B, IL1RAP, PTGS2, CCL5, CXCL10, and CASP14 levels in HaCat cells transfected with a miR&#8208;21&#8208;3p mimic or a scrambled sequence (control). IL6: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.05; IL1B: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.005; IL1RAP: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.008; PTGS2: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.050; CCL5: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.001; CXCL10: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;0.012; CASP14: control vs. miR&#8208;21&#8208;3p mimic P&#160;=&#160;9E&#8208;05. N&#160;=&#160;3 biological replicates, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>24862</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>25042</offset>
      <text>Given this pro&#8208;inflammatory role of miR&#8208;21&#8208;3p in keratinocytes, we next analyzed whether the higher levels of miR&#8208;21&#8208;3p observed in Ppard+/+ compared to Ppard&#8722;/&#8722; epidermis exposed to UV were associated with exacerbated inflammation in&#160;vivo. Like in human keratinocytes, a higher expression of miR&#8208;21&#8208;3p was indeed associated with at least double Il6, Il1b, Ptgs2, and Ccl5 mRNA expressions in Ppard+/+ compared to Ppard&#8722;/&#8722; epidermis after acute UV exposure (Fig&#160;5A), and UV&#8208;induced recruitment of macrophages was exacerbated in Ppard+/+ compared to Ppard&#8722;/&#8722; dermis (Fig&#160;5B). Moreover, miR&#8208;21&#8208;3p expression was also increased in other murine skin lesions associated with inflammation, such as chemically induced cutaneous murine papilloma and squamous cell carcinomas (Appendix&#160;Fig S2B), while moderate epidermal barrier disruption (obtained by tape stripping and monitored using involucrin as a control) did not cause an increase in miR&#8208;21&#8208;3p expression (Appendix&#160;Fig S2C). Interestingly, subcutaneous delivery of a miR&#8208;21&#8208;3p inhibitor in mice tended to reduce acute UV&#8208;induced inflammation as indicated by a reduction in UV&#8208;induced Il6, Ptgs2, and TNF&#8208;&#945; levels in the epidermis, although comparison with the control&#8208;treated epidermis did not reach statistical significance (Fig&#160;5C).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>26381</offset>
      <text>Elevated miR&#8208;21&#8208;3p level correlates with exacerbated inflammation in murine skin exposed to acute UV </text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>26487</offset>
      <text>RT&#8211;qPCR quantification of Il6, Il1b, Ptgs2 and Ccl5 levels in the epidermis of acutely irradiated (Ac&#8208;UV; +) and non&#8208;irradiated (&#8722;) Ppard+/+ and Ppard&#8722;/&#8722; mice. Il6: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;7E&#8208;04, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.008; Il1b: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;0.010, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.016, Ppard&#8722;/&#8722; no UV vs. Ac&#8208;UV P&#160;=&#160;0.015; Ptgs2: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;0.028, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.028, Ppard&#8722;/&#8722; no UV vs. Ac&#8208;UV P&#160;=&#160;8E&#8208;04; Ccl5: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;0.002, Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.014, Ppard&#8722;/&#8722; no UV vs. Ac&#8208;UV P&#160;=&#160;0.010; ns: non&#8208;significant. N&#160;=&#160;4 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>27325</offset>
      <text>Left panel: Immunostaining for infiltrating F4/80&#8208;positive macrophages in acutely irradiated (Ac&#8208;UV) and non&#8208;irradiated (no UV) Ppard+/+ and Ppard&#8722;/&#8722; mice skin sections. Scale bar: 200&#160;&#956;m. Right panel: RT&#8211;qPCR quantification of relative level of the macrophage marker Emr1 mRNA in total skin of acutely irradiated (Ac&#8208;UV; +) and non&#8208;irradiated (&#8722;) Ppard+/+ and Ppard&#8722;/&#8722; mice. Emr: Ppard+/+ no UV vs. Ac&#8208;UV P&#160;=&#160;0.034; Ppard+/+ Ac&#8208;UV vs. Ppard&#8722;/&#8722; Ac&#8208;UV P&#160;=&#160;0.033. N&#160;=&#160;4 animals per group, one representative experiment is shown out of three independent replicates.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>27928</offset>
      <text>RT&#8211;qPCR quantification of relative levels of Il6, Il1b, Ptgs2, and Tnfa in mouse epidermis acutely irradiated (Ac&#8208;UV; +) and non&#8208;irradiated (&#8722;), treated with miR&#8208;21&#8208;3p inhibitor (+) or mismatched control (&#8722;) as indicated.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>28164</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>28344</offset>
      <text>Collectively, these observations demonstrate that miR&#8208;21&#8208;3p promotes inflammation in human keratinocytes in culture. Consistently, high expression levels of miR&#8208;21&#8208;3p are associated with exacerbated inflammation in murine skin exposed to UV or to chemical carcinogens, while miR&#8208;21&#8208;3p inhibition in mouse skin in&#160;vivo tends to reduce acute UV&#8208;induced inflammation.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>28724</offset>
      <text>Inhibition of miR&#8208;21&#8208;3p is of clinical relevance in human skin</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>28791</offset>
      <text>We next investigated the relevance of miR&#8208;21&#8208;3p pro&#8208;inflammatory function in inflammatory human skin disorders. We found that, like in the murine skin, human cutaneous miR&#8208;21&#8208;3p expression was&#160;localized in the epidermis (Appendix&#160;Fig S2D). Importantly, miR&#8208;21&#8208;3p levels were higher in human squamous cell carcinoma (SCC; Fig&#160;6A, right panel) and in human psoriasis lesions (Fig&#160;6B, right panel) compared with healthy human skin. In line with a transcriptional activation of miR&#8208;21&#8208;3p expression, high level of miR&#8208;21&#8208;3p in these samples correlated with high levels of pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, and guide strand miR&#8208;21&#8208;5p (Fig&#160;6A and B), as well as with high levels of PPARD and TGFB1 mRNAs (Appendix&#160;Fig S2E and F). The observation that elevated miR&#8208;21&#8208;3p was associated with inflammation in murine skin exposed to UV, in human keratinocytes, and in human skin with inflammatory disorders raises the exciting possibility that miR&#8208;21&#8208;3p inhibitors may be used as therapeutic anti&#8208;inflammatory agents. We thus tested the hypothesis that inhibition of miR&#8208;21&#8208;3p would mitigate the inflammatory response in human skin subjected to acute UV exposure. A miR&#8208;21&#8208;3p LNA inhibitor or its scrambled control was topically applied on human abdominal skin ex&#160;vivo explants before and following acute UV exposure. Successful formation of the stable duplex between miR&#8208;21&#8208;3p and its LNA inhibitor in the epidermis was controlled by the lack of miR&#8208;21&#8208;3p PCR amplification in the LNA inhibitor&#8208;treated samples, while increase in miR&#8208;21&#8208;3p expression was detected as expected in scrambled&#8208;treated samples (Appendix&#160;Fig S2G). Treatment with the miR&#8208;21&#8208;3p inhibitor significantly reduced the peaks of IL6, IL1B, and PTGS2 in the human skin explants following UV exposure compared to control&#8208;treated biopsies (Fig&#160;6C), while the expression of TGFB1 was unaffected (Appendix&#160;Fig S2H).</text>
    </passage>
    <passage>
      <infon key="type">fig_title_caption</infon>
      <offset>30737</offset>
      <text>Elevated miR&#8208;21&#8208;3p and its inhibition are of clinical relevance to human skin inflammatory disorders</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>30842</offset>
      <text>RT&#8211;qPCR quantification of relative levels of pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, miR&#8208;21&#8208;5p, and miR&#8208;21&#8208;3p levels in healthy human skin and human squamous cell carcinomas (SCC). Pri&#8208;miR&#8208;21 healthy skin vs. SCC P&#160;=&#160;0.043; Pre&#8208;miR&#8208;21 healthy skin vs. SCC P&#160;=&#160;3E&#8208;05; miR&#8208;21&#8208;5p healthy skin vs. SCC P&#160;=&#160;7E&#8208;05; miR&#8208;21&#8208;3p healthy skin vs. SCC P&#160;=&#160;1.4E&#8208;06. n&#160;&#8805;&#160;5 independent biopsies per condition.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>31273</offset>
      <text>RT&#8211;qPCR quantification of relative levels of pri&#8208;miR&#8208;21, pre&#8208;miR&#8208;21, miR&#8208;21&#8208;5p, and miR&#8208;21&#8208;3p levels in healthy human skin and human psoriasis lesions. pri&#8208;miR&#8208;21 healthy skin vs. psoriasis P&#160;=&#160;0.034; miR&#8208;21&#8208;5p healthy skin vs. psoriasis P&#160;=&#160;0.034; miR&#8208;21&#8208;3p healthy skin vs. psoriasis P&#160;=&#160;0.036; ns: non&#8208;significant, n&#160;&#8805;&#160;4 independent biopsies per condition.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>31675</offset>
      <text>RT&#8211;qPCR quantification of relative levels of IL6, IL1B, PTGS2, and TNFA levels in epidermis of abdominal healthy human skin biopsies exposed to acute UV ex&#160;vivo, with or without topical treatment with miR&#8208;21&#8208;3p inhibitor (+) or mismatched control (&#8722;) as indicated. ns: not significant. IL6: no UV vs. Ac&#8208;UV P&#160;=&#160;0.036, Ac&#8208;UV vs. Ac&#8208;UV/miR&#8208;21&#8208;3p inhibitor P&#160;=&#160;0.019; IL1B: no UV vs. Ac&#8208;UV P&#160;=&#160;0.002, Ac&#8208;UV vs. Ac&#8208;UV/miR&#8208;21&#8208;3p inhibitor P&#160;=&#160;0.023; PTGS2: no UV vs. Ac&#8208;UV P&#160;=&#160;0.008, Ac&#8208;UV vs. Ac&#8208;UV/miR&#8208;21&#8208;3p inhibitor P&#160;=&#160;0.022; TNFA: no UV vs. Ac&#8208;UV P&#160;=&#160;0.032, ns&#160;=&#160;non&#8208;significant. n&#160;&#8805;&#160;7 replicates, a pool of three independent experiments performed with the skin of three different donors is shown.</text>
    </passage>
    <passage>
      <infon key="type">fig_caption</infon>
      <offset>32437</offset>
      <text> Data information: Results are presented as mean values &#177; SEM. The statistical comparison between groups was performed by using t&#8208;test. *P&#8208;value &lt;&#160;0.05; **P&#8208;value &lt;&#160;0.01.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>32617</offset>
      <text>These findings highlight the pathophysiological relevance of miR&#8208;21&#8208;3p upregulation in human inflammatory skin disorders and suggest that suppression of miR&#8208;21&#8208;3p activity may provide a therapeutic benefit, at least for the prevention of UV&#8208;induced skin inflammation.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>32895</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>32906</offset>
      <text>In this study, we describe a novel molecular cascade, involving a PPAR&#946;/&#948;&#8208; and TGF&#946;&#8208;dependent activation of miR&#8208;21&#8208;3p, which we identify as a UV&#8208;induced, pro&#8208;inflammatory miRNA in keratinocytes. This cascade is of pathophysiological importance since miR&#8208;21&#8208;3p levels are increased in murine and human skin exposed to UV, in human psoriatic skin, and in human squamous cell carcinomas compared to healthy tissue. Moreover, we show that topical administration of a miR&#8208;21&#8208;3p inhibitor on ex&#160;vivo human skin significantly reduces UV&#8208;induced inflammation. Thus, this study identifies miR&#8208;21&#8208;3p as a putative potent therapeutic target in the treatment of cutaneous inflammatory diseases.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>33619</offset>
      <text>Although miR&#8208;21&#8208;5p (commonly named miR&#8208;21) plays several recognized functions in the skin (Guo et&#160;al, 2009; Ma et&#160;al, 2011; Xu et&#160;al, 2012; Hou et&#160;al, 2013), its passenger miR&#8208;21&#8208;3p has attracted little attention in this organ to date, most likely due to its low basal expression. Contrary to the view that only one miRNA strand is functional, our study provides evidence that miR&#8208;21&#8208;3p expression is increased in keratinocytes upon various pathophysiological conditions, where it acts as a functional miRNA.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>34146</offset>
      <text>Using a combination of genetic and pharmacological approaches, we unravel that the remarkable increase of miR&#8208;21&#8208;3p in the epidermis exposed to UV involves the activation of PPAR&#946;/&#948; and of TGF&#946;1 signaling. While the regulation of pri&#8208;miR21 level by PPAR&#946;/&#948; is rather modest and likely involves other unidentified actors, the upregulation of mature miR&#8208;21&#8208;3p provoked by UV in&#160;vivo requires PPAR&#946;/&#948;. These data lead us to suggest that PPAR&#946;/&#948;&#8208;dependent regulation of miR&#8208;21&#8208;3p levels relies on combined activation of the transcription of pri&#8208;miR&#8208;21, reinforced downstream by post&#8208;transcriptional activation of its processing into mature miR&#8208;21&#8208;3p. The combination of PPAR&#946;/&#948; and TGF&#946;1 gain&#8208; and loss&#8208;of&#8208;function indicates that the PPAR&#946;/&#948;&#8208;dependent regulation of pri&#8208;miR&#8208;21 and miR&#8208;21&#8208;3p levels is indirect and requires TGF&#946; receptor activation. In line with our hypothesis that PPAR&#946;/&#948; regulates miR&#8208;21&#8208;3p at the transcriptional and post&#8208;transcriptional levels, TGF&#946; was also shown to activate the transcription of pri&#8208;miR&#8208;21 as well as its processing to mature miR&#8208;21&#8208;5p (Davis et&#160;al, 2008; Godwin et&#160;al, 2010; Zhong et&#160;al, 2011). The identification of the PPAR&#946;/&#948;/TGF&#946;1/miR&#8208;21&#8208;3p cascade provides a mechanism for miR&#8208;21&#8208;3p activation in response to UV, and it further suggests that miR&#8208;21&#8208;3p is a novel mediator of PPAR&#946;/&#948; and TGF&#946;1 activities. PPAR&#946;/&#948; and TGF&#946;1 are known to play critical roles in the maintenance of skin homeostasis (Di&#8208;Poi et&#160;al, 2004), in skin inflammation and skin carcinogenesis (Glick et&#160;al, 2008; Han et&#160;al, 2012; Montagner et&#160;al, 2013; Ravindran et&#160;al, 2014). Given that PPAR&#946;/&#948; and TGF&#946;1 functions are, by far, not limited to the epidermis, a broader involvement of miR&#8208;21&#8208;3p in mediating their functions remains open and requires further investigation.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>36042</offset>
      <text>The canonical mode of miRNA action involves the downregulation of multiple targets, either by stimulating mRNA degradation or by inhibiting mRNA translation. We identify human SMAD7 as a direct target of miR&#8208;21&#8208;3p. However, following UV irradiation, the mouse Smad7 expression level does not anti&#8208;correlate with that of miR&#8208;21&#8208;3p in the epidermis, but correlates with that of TGF&#946; and IL&#8208;1&#946;, in line with the fact that Smad7 is a direct TGF&#946; target gene (Nakao et&#160;al, 1997; Stopa et&#160;al, 2000), also known to be upregulated by IL&#8208;1&#946; (Bitzer et&#160;al, 2000). Although miR&#8208;21&#8208;3p likely contributes to the regulation of its target at the post&#8208;transcriptional level, Smad7 is under unsurprising complex regulations in&#160;vivo. Besides SMAD7, in silico analyses predicted a whole repertoire of targets for miR&#8208;21&#8208;3p, in line with the hypothesis that miR&#8208;21&#8208;3p pro&#8208;inflammatory role most likely relies on the complex regulation of multiple mRNA targets, whose study goes beyond the scope of this manuscript.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>37075</offset>
      <text>Although frequently viewed as an anti&#8208;inflammatory transcription factor (Michalik &amp; Wahli, 2007), PPAR&#946;/&#948; regulation of inflammation is complex and is context dependent. Previous work has shown that its activation with an agonist decreased inflammatory symptoms in mouse models of contact dermatitis (Plager et&#160;al, 2007; Kim et&#160;al, 2014), and cutaneous inflammatory response after 12&#8208;O&#8208;tetradecanoylphorbol&#8208;13&#8208;acetate (TPA) treatment was exacerbated in PPAR&#946;/&#948;&#8208;deficient mice (Man et&#160;al, 2008). In contrast to these anti&#8208;inflammatory actions, PPAR&#946;/&#948; increased expression in murine epidermis provoked a psoriasis&#8208;like phenotype, and its expression is elevated in human psoriatic lesions (Appendix&#160;Fig S2F), where it was proposed to contribute to the&#160;persistence of activated T cells (al Yacoub et&#160;al, 2008; Romanowska et&#160;al, 2010). Like PPAR&#946;/&#948;, TGF&#946;1 exhibits a context&#8208;dependent regulation of skin inflammation (Li et&#160;al, 2004; Glick et&#160;al, 2008; Han et&#160;al, 2012). Of note, it was recently demonstrated to promote UV&#8208;induced cutaneous inflammation and tumor formation (Glick et&#160;al, 2008; Ravindran et&#160;al, 2014) and to activate the expression of miR&#8208;31, another keratinocyte pro&#8208;inflammatory miRNA of relevance in psoriasis (Xu et&#160;al, 2013). In line with a pro&#8208;inflammatory role of PPAR&#946;/&#948; in response to UV, we show that the skin of Ppard+/+ mice displays exacerbated inflammation in response to UV compared to those of Ppard&#8722;/&#8722; animals. Our finding that miR&#8208;21&#8208;3p is activated by the PPAR&#946;/&#948;/TGF&#946;1 axis provides a mechanism for their pro&#8208;inflammatory actions in the skin. Moreover, our present report raises the hypothesis that the procarcinogenic role we described for PPAR&#946;/&#948; in the murine skin exposed to UV (Montagner et&#160;al, 2013) is also mediated by higher chronic inflammation, to which contributes activation of miR&#8208;21&#8208;3p. In line with our study, and while the present manuscript was in revision, Ge and collaborators demonstrated that miR&#8208;21&#8208;3p was involved in skin squamous cell carcinoma progression (Ge et&#160;al, 2015). Whether the pro&#8208;inflammatory role of miR&#8208;21&#8208;3p extends to other tissues remains to be explored. In support of a broader pathophysiological role of miR&#8208;21&#8208;3p, it was recently described as a fibroblast&#8208;derived paracrine mediator that promotes cardiomyocyte hypertrophy (Bang et&#160;al, 2014) and its expression was reported in inflamed aortic endothelial cells (Bang et&#160;al, 2014), epithelial and hematolymphoid cancers, and sarcomas (Aure et&#160;al, 2013; Ge et&#160;al, 2015).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>39660</offset>
      <text>From a preclinical perspective, we demonstrate that topical inhibition of miR&#8208;21&#8208;3p in ex&#160;vivo human skin explants is sufficient to significantly reduce the epidermal response to acute UV exposure. Surprisingly, while few recent data suggested that miRNAs may be involved in the response to UV exposure in isolated cell cultures (Guo et&#160;al, 2009; Pothof et&#160;al, 2009; Dziunycz et&#160;al, 2010), their involvement in the global response of human skin to UV has not been addressed. Our data not only reveal miR&#8208;21&#8208;3p as an inflammatory mediator in human skin response to UV, but they also suggest that miR&#8208;21&#8208;3p inhibition is of therapeutic interest as an anti&#8208;inflammatory molecule in this context. Targeting miRNA for anti&#8208;cancer therapeutic purposes has been successful in various murine models (reviewed in Kasinski &amp; Slack 2011). In these models, miRNA&#8208;based therapy demonstrated promising benefit with limited side effects. In the skin, delivery of miR&#8208;483&#8208;3p or miR&#8208;203 was shown to reduce the growth of subcutaneous squamous cell carcinoma (Bertero et&#160;al, 2013) or of basal cell carcinoma (Sonkoly et&#160;al, 2012), respectively, while silencing miR&#8208;21&#8208;5p provided therapeutic benefit in a preclinical model of patient&#8208;derived psoriatic lesions transplanted in immunocompromised mice (Guinea&#8208;Viniegra et&#160;al, 2014). Here, we propose that silencing of miR&#8208;21&#8208;3p, as a single or combined therapy, may be of relevance to protect against inflammatory dermatoses caused by solar radiation, especially in the case of UV hypersensibility pathologies and UV&#8208;based phototherapy. Finally, as numerous miRNAs were either shown or predicted to regulate inflammation and cytokines, non&#8208;invasive topical targeting of miRNA is a valuable approach to explore to improve treatment of skin inflammatory disorders, which remain a significant therapeutic challenge. Topical delivery of miRNA&#8208;based therapy will likely decrease the risk for side effects, although further research is required to develop safe RNA chemistry and delivering agents able to cross the epidermal barrier.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>41766</offset>
      <text>Materials and Methods</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>41788</offset>
      <text>Animal experimentation</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>41811</offset>
      <text>All experiments involving animals were approved by the Veterinary Office of the Canton Vaud (Switzerland) in accordance with the Federal Swiss Veterinary Office Guidelines and conform to the Commission Directive 86/609/EEC. Mice were raised and housed in a standard colony (4&#8211;5 animals per cage), in a temperature&#8208; and light&#8208;controlled environment (12/12&#8208;h light/dark cycle) and maintained with water and food ad&#160;libitum. Animals were hairless albino SKH&#8208;1/Ppard+/+ and SKH&#8208;1/Ppard&#8722;/&#8722; females, 8&#8211;12&#160;week old, maintained on a mixed genetic background (SKH1&#8208;C57/Bl6&#8208;SV129). Ppard+/+ and Ppard&#8722;/&#8722; were littermates. Each experiment involved four animals per group, randomly assigned to treatments, and was repeated independently. Skin samples were all collected from euthanized mice. UV irradiation: Briefly, mice from different litters were exposed to a single dose of 120&#160;mJ/cm2 of UVB for acute UV exposure, or to a dose of 70&#160;mJ/cm2 of UVB three times a week during a maximum period of 30&#160;weeks as described for chronic exposure (Montagner et&#160;al, 2013). Non&#8208;irradiated (sham manipulated) aged&#8208;matched mice were used as controls. Total RNA containing the small RNA fraction was isolated from control skins, skins 24&#160;h after acute UV exposure, lesion&#8208;free skins after 12&#160;weeks of chronic exposure, papilloma, and SCCs biopsies. PPAR&#946;/&#948; inhibition: Two hundred microliters of GSK0660 (Sigma; 625&#160;&#956;g/&#956;l in 70% ethanol) was applied topically on the back of the animals, 1&#160;h prior to UV exposure. TGF&#946;1 inhibition: Hundred microliters of the receptor kinase inhibitor SB431542 (Axon Medchem; 10&#160;mM in DMSO) was topically applied on the back of the animals 15&#160;min before and after acute exposure. Skin was then harvested and processed for dermis/epidermis separation 24&#160;h after UV exposure. In vivo miR&#8208;21&#8208;3p inhibition: miR&#8208;21&#8208;3p inhibitor (fluorescently labeled in&#160;vivo miRCURY LNA&#8482; Exiqon) or mismatch control in water was injected subcutaneously (10&#160;mg/kg) 6&#160;h before and 1&#160;h following acute UV irradiation. Skin was harvested and processed for dermis/epidermis separation 24&#160;h after UV exposure. Tape stripping: Back skin of hairless mice was stripped 10 times with ordinary adhesive tape. For each stripping, a fresh piece of tape was lightly pressed onto the skin and pulled off. Twenty&#8208;four hours after tape stripping, the skin was harvested and processed for dermis/epidermis separation. DMBA/TPA carcinogenesis: Six&#8208;week&#8208;old C57BL/6J female mice (N&#160;=&#160;45) were subjected to DMBA two&#8208;hit multistage skin carcinogenesis protocol as previously described (Owens et&#160;al, 1999). Mice were shaved 2&#160;days before initiation and regularly during the protocol. Mice were topically treated with 200&#160;nmol of DMBA in 0.2&#160;ml acetone. One&#160;week later, mice were treated twice a week for 6&#160;weeks with 5&#160;nmol PMA (phorbol 12&#8208;myristate 13&#8208;acetate) in 0.2&#160;ml acetone. A second hit of DMBA was performed on the eighth week followed by the resumption of PMA treatment for 14 more weeks as described above. Control mice were topically treated with 0.2&#160;ml acetone vehicle. Mice were monitored weekly for papilloma and tumors counting. Control skin (acetone treated), hyperplastic skin, papilloma, and tumors were harvested throughout the protocol, and biopsies were frozen for RNA extractions.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>45169</offset>
      <text>Epidermis and dermis separation</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>45201</offset>
      <text>Epidermis and dermis were prepared from whole dorsal skin of mice according to the protocol developed by Clemmensen et&#160;al (2009). After dorsal skin harvest, adipose tissue was removed with a scalpel on ice; the skin was cut into thin strips (1&#8211;2&#160;mm in large) and immediately incubated for 15&#160;min at RT in ammonium thiocyanate (3.8% in PBS 1&#215;). Epidermis and dermis were then separated mechanically with forceps and scalpel. Reverse transcription followed by qPCR was performed for specific epidermal (keratins 10 and 14) and dermal (collagen 14&#945;1) markers to check for proper separation of the two compartments.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>45820</offset>
      <text>MiRNA in&#160;situ hybridization with Locked nucleic acid (LNA) probes</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>45887</offset>
      <text>Skin samples were fixed and cryopreserved at 4&#176;C in 4% in paraformaldehyde and 30% sucrose overnight. Samples were then frozen in optimum cutting temperature matrix (OCT) at &#8722;80&#176;C, further cut into 10&#8208;&#956;m sections (Cryostat, Leica), and mounted on slides. During the acetylation step, sections were washed in 0.1&#160;M of triethanolamine/10&#160;min and then in triethanolamine/0.25% acetic anhydride/10&#160;min. Hundred microliters of digoxigenin&#8208;labeled LNA probes (Exiqon, 25&#160;nM in hybridization buffer) was added on each section, and hybridization was performed O/N (16&#160;h) at 54&#176;C (20&#176;C below probes melting temperature) in a humid chamber. Following hybridization, sections were washed three times with 0.2&#215; SCC/20&#160;min/60&#176;C and equilibrated in TN buffer (100&#160;mM Tris&#8211;HCl pH 7.5, 150&#160;mM NaCl) for 5&#160;min at room temperature. Sections were then blocked in TNB buffer (0.5% blocking reagent, PerkinElmer in TN buffer) for 30&#160;min at room temperature. To quench peroxidase activity, the slides were incubated in 3% H2O2 for 1&#160;h and washed with TNT (0.05% Tween&#8208;20 in TN buffer) 3&#160;&#215;&#160;5&#160;min. Diluted anti&#8208;DIG&#8208;POD 1:500 in TNB was applied and incubated for 30&#160;min at room temperature. After three washes with TNT 3&#160;&#215;&#160;5&#160;min, slides were incubated 10&#160;min at room temperature with diluted Cy3&#8208;tyramide 1:50 in amplification reagent (TSATM Plus Cy5 Fluorescence System, PerkinElmer). Finally, slides were washed with TNT 3&#160;&#215;&#160;5&#160;min and mounted in Mowiol.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47366</offset>
      <text>LNA probes were designed by Exiqon:</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47402</offset>
      <text>mmu&#8208;miR&#8208;21&#8208;3p: 5DigN/GACAGCCCATCGACTGCACTGCTGTTG/3Dig_N/</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47465</offset>
      <text>has&#8208;miR&#8208;21&#8208;3p: 5DigN/CAACACCAGUCGAUGGGCUGU/3Dig_N/</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47522</offset>
      <text>Scramble&#8208;miR:/5DigN/GTGTAACACGTCTATACGCCA/3Dig_N/</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47574</offset>
      <text>  </text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>47577</offset>
      <text>Western blot for SMAD7 and Smad7</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>47610</offset>
      <text>Anti&#8208;human and mouse SMAD7/Smad7 antibodies were purchased from Abcam (catalogue number ab124890). Anti&#8208;human and anti&#8208;mouse GAPDH antibody was from Cell Signaling Technologies (catalogue number 2118). Ten micrograms (HaCat cells) or 20&#160;&#956;g (mouse epidermis) of proteins was separated on SDS&#8211;polyacrylamide&#160;gels. Proteins were then transferred onto a polyvinylidene filter in semidry conditions (PerfectBlue peqlab). Membranes were incubated overnight with anti&#8208;SMAD7/Smad7 primary antibody (1:1,000) in 5% BSA and then 1&#160;h with anti&#8208;rabbit IgG&#8208;HRP antibody (1:30,000; Promega) in 1% BSA. GAPDH was used as a loading control (1:10,000; 1% BSA). Signals were detected using&#160;Western Bright Quantum (Advansta)&#160;and Fusion FX (Vilber&#160;Lourmat) and quantified with the Bio1D software (Vilber Lourmat).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>48425</offset>
      <text>F4/80 macrophages detection</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>48453</offset>
      <text>Immunohistochemical detection of the macrophage marker F4/80 was performed on hairless mice skin paraffin sections using rat anti&#8208;F4/80 primary antibody (1:800) (Abcam, catalogue number ab6640) incubated overnight at 4&#176;C in 2.5% NGS buffer and a goat anti&#8208;rat HRP as a secondary antibody (Biosource, catalogue number AR 13404) incubated during 40&#160;min in 2.5% NGS buffer at room temperature.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>48850</offset>
      <text>Patient SCC and psoriasis biopsies</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>48885</offset>
      <text>Cutaneous SCC samples were obtained anonymously from the Department of Dermatology, University Hospital of Lausanne, Switzerland. Normal skin was from healthy adult volunteers or from the edges of skin tumors. Experienced pathologists diagnosed SCC biopsies.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>49144</offset>
      <text>Cutaneous psoriasis samples were obtained anonymously from the Department of Dermatology, Universit&#228;ts Spital Z&#252;rich, Switzerland. Psoriasis samples were obtained from adult volunteers and diagnosed by experienced pathologists. Informed consent for research was obtained prior to routine diagnostic services.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>49455</offset>
      <text>Human skin ex&#160;vivo explant culture and miR&#8208;21&#8208;3p inhibitor topical application</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>49539</offset>
      <text>Abdominal skin biopsies were obtained anonymously from the Department of Internal Medicine, University Hospital of Geneva, Switzerland, and from the Department of Musculoskeletal Medicine Biobank, University Hospital of Lausanne, Switzerland. Informed consent for research was obtained prior to surgery. For those samples obtained from Department of Musculoskeletal Medicine Biobank, informed consent was regulated through the Department of Musculoskeletal Medicine Biobank (University Hospital of Lausanne, Switzerland) with Profs. Raffoul and Applegate. Immediately after surgery, human abdominal skin was cleaned from its adipose tissue and 0.5&#160;mm2 biopsies were deposed on adjusted agar&#8208;based bed&#8208;filled dishes and incubated in humidified incubator at 37&#176;C with 5% CO2 for 24&#160;h. Topical application of the miR&#8208;21&#8208;3p&#8208;based lotion was performed 24 and 2&#160;h before UV irradiation (120&#160;mJ/cm2), immediately and 2&#160;h after UV irradiation. Skin was processed for dermis&#8211;epidermis separation prior to RNA extraction 18&#8211;24&#160;h after UV irradiation. Agar&#8208;based bed&#8208;filled dishes: 0.25&#160;g of agar powder was diluted in 10&#160;ml of sterilized water and heated for 1&#160;min (microwave). One milliliter of agar mix was added for each 10&#160;ml of DMEM GlutaMAX&#8208;I media (Gibco), 20% of FBS, and 1% of antibiotic (penicillin/streptomycin). Six milliliters of this solution was quickly added to 6&#8208;cm petri dishes. When solidified, a &#8220;bed&#8221; was dug in the agar in which skin biopsy was deposed, epidermis remaining at surface. MiR&#8208;21&#8208;3p&#8208;based lotion: A 9:1:1:8 mix of glycerol:DMSO: transfection reagent (RNAimax, Invitrogen):50&#160;&#956;M of miR&#8208;21&#8208;3p LNA inhibitor (Exiqon, I&#8208;has&#8208;miR&#8208;21&#8208;3p) or its control (Exiqon, MM&#8208;has&#8208;miR&#8208;21&#8208;3p) diluted in PBS was prepared. Sixteen microliters of this miR&#8208;21&#8208;3p antagonist&#8208;based lotion was applied to each 0.5&#160;mm2 biopsies, 24 and 2&#160;h before UV irradiation, immediately, 2 and 24&#160;h after UV irradiation. Skin was processed for dermis&#8211;epidermis separation prior to RNA extraction 24&#160;h after UV irradiation.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>51625</offset>
      <text>Cell culture, transfection, and treatments</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>51668</offset>
      <text>Human immortalized keratinocytes HaCaT (Cell Line Service; Germany) cells were maintained in DMEM growth medium (Gibco) supplemented with 4,500&#160;mg/l glucose, 10% fetal bovine serum, 100&#160;units/ml of penicillin G, and 100&#160;&#956;g/ml of streptomycin. Cells were grown in a 5% CO2 atmosphere at 37&#176;C. Assignment to various treatments was randomized. PPAR&#946;/&#948; activation: PPAR&#946;/&#948; agonists GW0742 or GW501516 in DMSO were added at a final concentration of 0.5&#160;&#956;M, and cells were harvested after 24&#160;h of treatment. miR&#8208;21&#8208;3p gain of function: miR&#8208;21&#8208;3p mimic (miRIDIAN, Thermo Scientific Dharmacon) or cel&#8208;miR&#8208;67&#8208;3p used as a control (miRIDIAN, Thermo Scientific Dharmacon) was transfected to the cells at a concentration of 50&#160;nM using the Lipofectamine RNAimax (Invitrogen). Cells were harvested 24&#160;h after transfection for gene expression analysis. TGF&#946;1 treatment: Cells were grown for 24&#160;h in the presence of 2&#160;ng/ml or 5&#160;ng/ml of human TGF&#946;1 (reconstituted in 5&#160;mM HCl, Prospec) or vehicle (PBS containing 2&#160;mg/ml of albumin). Combined TGF&#946;1 inhibition and PPAR&#946;/&#948; activation: TGF&#946; type I receptor kinase (ALK5) inhibitor SB431542 (Axon Medchem) 2&#160;&#956;M in DMSO was added to the cells for 24&#160;h. The PPAR&#946;/&#948; activator GW0742 was then added&#160;to cells at a final concentration of 0.5&#160;&#956;M in DMSO. Cells were harvested 24&#160;h later. Cycloheximide treatment: HaCaT cells were&#160;treated for 6&#160;h with vehicle (DMSO) or PPAR&#946;/&#948; agonist GW0742 (5&#160;&#956;M) in the presence or in the absence of cycloheximide (1&#160;&#956;g/ml).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>53212</offset>
      <text>Luciferase assays</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>53230</offset>
      <text>Wild&#8208;type SMAD7 3&#8242;UTR was purchased from OriGene (Clone NM_005904). Mutant SMAD7 3&#8242;UTR was obtained by PCR mutagenesis of the wild&#8208;type SMAD7 3&#8242;UTR, followed by sequencing for quality control (Fig&#160;3B). Mycoplasm&#8208;free (MycoAlert, Lonza) human embryonic kidney (HEK) 293 cells (gift from Prof. W. Herr, University of Lausanne) were maintained in DMEM + 10% FBS. HEK 293 cells were transfected (Lipofectamine RNAimax) with pRL for standardization (Renilla luciferase reporter under CMV promoter, 0.625&#160;ng/ml), miR&#8208;21&#8208;3p mimic or scrambled sequence (miRIDIAN, Thermo Scientific Dharmacon, 50&#160;nM), and Firefly luciferase reporter&#8212;wild&#8208;type or mutant Smad7 3&#8242;UTR reporter (40&#160;ng/ml). Cells were harvested 24&#160;h after transfection for luciferase assay analysis (Dual&#8208;Glo&#174; Reporter Assay System, Promega) using the Microplate luminometer GloMax&#174;&#8208;9 (Promega).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>54113</offset>
      <text>Extraction of total RNA, reverse transcription, and real&#8208;time PCR</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>54181</offset>
      <text>Total RNA was isolated using TRIzol reagent (Invitrogen). Quality of the RNA was assessed using a BioAnalyzer (Agilent). One microgram of total RNA was reverse&#8208;transcribed with random hexamer primers (Promega) using the SuperScriptII Reverse Transcriptase (Invitrogen). Real&#8208;time PCR was performed with SYBR Green PCR Master Mix (Applied Biosystems) using Stratagene Mx3000P thermo cycler. mRNA expression was related to the expression of the housekeeping genes GAPDH and Ef1a1 for murine samples and to RPL27 and HPRT1 or ACTB for human samples and cells (GeNorm, M value &lt;&#160;0.5). For miRNA, reverse transcription was performed using the Exiqon miRCURY LNA&#8482; Universal RT microRNA kit. Quantitative PCR was performed according to manufacturer protocol with microRNA LNA&#8482; PCR primer sets and SYBR Green PCR Master Mix (Applied Biosystems) on a Stratagene Mx3000P thermo cycler. MiR&#8208;103 and sno234 were used as control for normalization.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>55127</offset>
      <text>Expression of mature mmu&#8208;miR&#8208;21&#8208;3p and mmu&#8208;miR&#8208;21&#8208;5p in control skin (acetone treated), DMBA/TPA&#8208;treated hyperplastic skin, papilloma, and tumors was evaluated using TaqMan MicroRNA Assays (Applied Biosystems) and the Lightcycler 480 detection system (Roche Applied Science, Indianapolis, IN, USA). Expression levels were normalized to mmu&#8208;SnoR55.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>55491</offset>
      <text>Quantification of relative expression was based on the determination of the threshold cycle (Ct).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>55589</offset>
      <text>mRNA primers</text>
    </passage>
    <passage>
      <infon key="type">table</infon>
      <offset>55602</offset>
      <text>   Name Forward Reverse   mmu&#8208;GAPDH GTATGACTCCACTACGGCAAA TTCCCATTCTCGGCTTG  mmu&#8208;Eef1a1 CCTGGCAAGCCCATGTGT TCATGTCACGAACAGCAAAGC  mmu&#8208;Ppard CGGCAGCCTCAACATGG AGATCCGATCGCACTTCTCATAC  hsa&#8208;PPARD GCATGAAGCTGGAGTACGAGAAG GCATCCGACCAAAACGGATA  hsa&#8208;SERPINE1 GGCTGACTTCACGAGTCTTTCA ATGCGGGCTGAGACTATGACA  hsa&#8208;p21 (CDKN1A) CTCAGAGGAGGCGCCATGTCAGAAC GCAGCCCGCCATTAGCGCAT  hsa&#8208;RUNX TCGCTTTCAAGGTGG TGGCCC GCGGTAGCATTTCTCAGCTCAGCC  hsa&#8208;SNAI2 AGCGAACTGGACACACATACAGTGAT GCGTGGAATGGAGCAGCGGTA</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56098</offset>
      <text>  </text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56101</offset>
      <text>ANGPTL/Angptl4, TGFB1/Tgfb1, RPL27/Rpl27, HPRT1/Hprt, SMAD7/Smad7, Emr1, CASP14/Casp14, CCL5/Ccl5, CXCL10/Cxcl10, IL1B/ll1b, IL1RAP/Il1rap, PTGS2/Ptgs2, IL6/Il6, TNFA/Tnfa, COL4A1/Col4a1, KRT5/Krt5, and IVL/Ivl have been purchased from Qiagen (QuantiTect primers).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>56366</offset>
      <text>miRNA primers</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56380</offset>
      <text>mmu/hsa&#8208;miR&#8208;21&#8208;3p, mmu/hsa&#8208;miR&#8208;21&#8208;5p, mmu/hsa&#8208;miR&#8208;103, and a customized hsa&#8208; and mmu&#8208;pre&#8208;miR&#8208;21 primers have been purchased from Exiqon (microRNA LNA PCR primer sets).</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56572</offset>
      <text>hsa&#8208;pri&#8208;miR&#8208;21: forward&#8208;TTTTGTTTTGCTTGGGAGGA; reverse AGCAGACAGTCAGGCAGGAT.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56656</offset>
      <text>mmu&#8208;pri&#8208;miR&#8208;21: forward&#8208;CCAGAGATGTTTGCTTTGCTT; reverse&#8208;TGCCATGAGATTCAACAG.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>56741</offset>
      <text>mRNA microarray data analysis/pathway analysis</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>56788</offset>
      <text>All RNA quantities were assessed by NanoDrop&#174;ND&#8208;1000 spectrophotometer and the RNA quality was assessed using RNA 6000 NanoChips with the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, USA). For each sample, 100&#160;ng of total RNA was amplified using the Ambion&#174; WT Expression Kit (4411973, Life Technologies) kit. 5.5&#160;&#956;g of the cDNA was fragmented and labeled with GeneChip&#174; WT Terminal Labeling kit (901525, Affymetrix). Affymetrix mouse gene 1.0ST arrays (Affymetrix, Santa Clara, CA, USA) were hybridized with 2.3&#160;&#956;g of fragmented target, at 45&#176;C for 16&#160;h washed and stained according to the protocol described in Affymetrix GeneChip&#174; Expression Analysis Manual (Fluidics protocol FS450_0007). Background subtraction, quantile normalization, and probeset summarization were performed with the Affymetrix Power Tools command line tool, using the RMA method. Normalized chip data were stored as ExpressionSet objects in R using the Bioconductor affy and affyPLM packages. Differentially expressed genes between conditions were detected by applying the empirical Bayes method (limma package in R; Gentleman et&#160;al, 2004; Smyth, 2004) and ranked according to fold change. Four biological replicates for each group (non&#8208;irradiated mice, 12&#160;weeks irradiated mice or miR&#8208;21&#8208;3p mimic and control&#8208;treated HaCaT cells) were used for the differential expression analysis. P&#8208;values were adjusted for multiple comparisons using the Benjamini&#8211;Hochberg procedure (Benjamini &amp; Hochberg, 1995), and genes with an adjusted P&#8208;value of &lt;&#160;0.01 were considered as differentially expressed. Gene enrichment analysis has been realized with DAVID version 6.7 (the Database for Annotation, Visualization and Integrated Discovery) identifying enriched biological GO terms (da Huang et&#160;al, 2009).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>58587</offset>
      <text>miRNA microarray data analysis</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>58618</offset>
      <text>Each RNA skin sample was prepared according to the Agilent's miRNA Microarray System protocol and loaded on the mouse microarray (Mouse miRNA Microarray Release 16.0). Normalization procedures were based on the invariant procedure and the quantile normalization as described in Pradervand et&#160;al (2009). After normalization, the limma package in R was used to define a linear regression for inter&#8208;conditions fold change calculation as for the microarray analysis. P&#8208;values were adjusted for multiple comparisons using the Benjamini&#8211;Hochberg procedure (Benjamini &amp; Hochberg, 1995), and miRNAs with a P&#8208;value of &lt;&#160;0.001 and absolute fold change of at least 1.5 were selected as differentially regulated.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>59329</offset>
      <text>RNA&#8208;Seq (miRNA) in mouse skin</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>59361</offset>
      <text>High&#8208;quality RNA were extracted from the 16 dermis and epidermis samples of hairless Ppard+/+ and Ppard&#8722;/&#8722; mice acutely irradiated or not irradiated (control) using TRIzol standard extractions. Small RNA libraries were prepared using 1&#160;&#956;g of total RNA according to the TruSeq Small RNA Sample Preparation Guide (Illumina, San Diego, CA). Libraries were sequenced either on the Illumina HiSeq 2000 (26 samples) or on the HiSeq 2500 (44 samples) using v3 chemistry.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>59833</offset>
      <text>Formatting and processing of sequence reads: Sequence reads were processed to remove the adaptor sequences and reformatted to&#160;FASTA files using the FASTX&#8208;Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html). To generate count data, the raw&#160;sequences were compared to mouse mature microRNA sequences (from miRBase version 17) and non&#8208;coding RNA sequences (Rfam version 10) using MEGABLAST with a word size of 8 nucleotides. The criteria for counting a sequence match were if the % query was &#8805;&#160;90% of the target sequence and if there were &#8804;&#160;2 mismatches over the alignment. The % query was calculated as (a/q)&#160;&#215;&#160;p where a&#160;=&#160;alignment length, q&#160;=&#160;query length, and p&#160;=&#160;percent identity over aligned region. The matches against miRBase were parsed and the top matches (based on % query) were selected. If a sequence had more than one top match against different database sequences, it was excluded from the subsequent analysis. Matches to Rfam were only taken into account for sequences not matching miRBase. Statistical analysis of microRNA counts: Counts for mouse mature microRNAs were used to test for differential expression. Count data from Rfam microRNAs were excluded since these sequences may represent non&#8208;mature microRNAs. To perform the analysis, count data were fitted to a statistical model based on the negative binomial distribution using the R package DESeq, which is useful for detecting significant RNA&#8208;Seq variation with a low number of biological replicates (Anders &amp; Huber, 2010). To perform the normalization and differential expression analysis, raw read counts per gene were normalized to the relative size of each library. Empirical dispersion (the squared coefficient of variance for each gene) was estimated using the pooled method. Here, samples from all conditions with replicates are used to estimate a single pooled dispersion value, which is applied to&#160;all&#160;samples. The dispersion&#8211;mean relationship was then fitted&#160;using the local method and the maximum of the fitted and empirical values was used in subsequent calculations. The&#160;difference between the means of KO vs. WT samples was then calculated using a negative binomial test and P&#8208;values were&#160;adjusted for multiple comparisons using the Benjamini&#8211;Hochberg method (Benjamini &amp; Hochberg, 1995). miRNA with an adjusted P&#8208;value of &#8804;&#160;0.05 was considered to be differentially expressed.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>62248</offset>
      <text>RNA&#8208;Seq reads of miR&#8208;21&#8208;3p in mouse brain, heart, kidney, and testis tissues</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>62331</offset>
      <text>RNA&#8208;Seq reads of miR&#8208;21&#8208;3p were obtained from high&#8208;quality RNA of mouse brain, heart, kidney, and testis samples. Small RNA&#8208;seq libraries and sequencing protocols are described in (Meunier et&#160;al, 2013).</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>62545</offset>
      <text>Statistical analyses</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>62566</offset>
      <text>Results are presented as mean values&#160;&#177;&#160;standard error of mean (SEM). Unless mentioned otherwise, the statistical comparison between groups was performed by using t&#8208;test, a maximum of three comparisons were performed per panel, and robustness of&#160;statistical significance was verified after correction for multiple&#160;testing. Probability was considered to be significant at P&#160;&lt;&#160;0.05.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>62955</offset>
      <text>Data availability</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>62973</offset>
      <text>Primary data: Data access: NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) accession number GSE80431.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63097</offset>
      <text>Referenced data:</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63114</offset>
      <text>Meunier et&#160;al (2013)</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63136</offset>
      <text>NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) accession number GSE40499.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>63233</offset>
      <text>Author contributions</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63254</offset>
      <text>GD, IDE, CP, AM, JM, RR, and GP designed and performed experiments and analyzed the data. FS analyzed the data and performed statistical analyses. NCB, DH, AK, PJ, and GH collected, classified, and provided patient biopsies of healthy skin, SCC, and psoriasis lesions. MI analyzed RNA sequencing data. IX designed microarray experiments. AB, LMu, and MS performed experiments. LMi supervised the project, designed experiments, and analyzed the data. GD and LMi wrote this manuscript. All authors reviewed the manuscript.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>63775</offset>
      <text>Conflict of interest</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63796</offset>
      <text>The authors declare that they have no conflict of interest.</text>
    </passage>
    <passage>
      <infon key="type">title_1_caption</infon>
      <offset>63856</offset>
      <text>The paper explained</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>63876</offset>
      <text>Problem</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>63884</offset>
      <text>The skin offers effective permeability barrier and provides protection against harmful conditions. Excessive UV exposure disrupts this barrier, provoking inflammation, premature aging, and ultimately, UV&#8208;induced carcinogenesis. Beyond UV&#8208;induced inflammation, skin disorders accompanied by acute or chronic inflammation are the most common dermatological pathologies. They remain a significant therapeutic challenge and represent a heavy personal burden as well as enormous costs for society. Despite the prevalence of these diseases, the complexity of the underlying molecular mechanisms remains incompletely characterized. Further studies of these mechanisms will provide novel and alternative therapeutic targets to explore in order to improve treatment of skin inflammatory disorders.</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>64677</offset>
      <text>The nuclear hormone receptor peroxisome proliferator&#8208;activated receptor &#946;/&#948; (PPAR&#946;/&#948;) regulates inflammation and promotes skin healing following an injury, through activation of keratinocyte proliferation, survival, and migration. In contrast to these beneficial functions, we recently showed that activation of PPAR&#946;/&#948; also favored the progression of UV&#8208;induced skin squamous cell carcinoma in mouse. In order to get further insights into the mechanisms underlying these functions of PPAR&#946;/&#948;, we explored miRNA that would orchestrate the PPAR&#946;/&#948;&#8208;dependent skin response to UV exposure. While miRNA are widely recognized as important players in skin homeostasis and functions, their involvement in skin response to UV has not been addressed.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>65454</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>65462</offset>
      <text>We used SKH&#8208;1 hairless albino mice lacking PPAR&#946;/&#948;, human keratinocytes, and human skin explants in culture, which are all relevant model for studying skin inflammatory responses. We unveil that upon UV exposure, PPAR&#946;/&#948; activates the expression of the passenger miRNA miR&#8208;21&#8208;3p. We identify miR&#8208;21&#8208;3p as a novel UV&#8208;induced miRNA in keratinocytes. We establish that miR&#8208;21&#8208;3p upregulation by PPAR&#946;/&#948; in response to UV is indirect and requires activation of the TGF&#946;1 receptor. We further show that miR&#8208;21&#8208;3p plays a pro&#8208;inflammatory role in keratinocytes and that its increase in human skin is of pathophysiological importance, as we found elevated levels of miR&#8208;21&#8208;3p in human skin exposed to UV, in human squamous cell carcinoma and human psoriatic lesions. Importantly, we provide evidence that inhibition of miR&#8208;21&#8208;3p reduces cutaneous inflammation in ex&#160;vivo human skin biopsies exposed to UV.</text>
    </passage>
    <passage>
      <infon key="type">title_2</infon>
      <offset>66399</offset>
      <text>Impact</text>
    </passage>
    <passage>
      <infon key="type">paragraph</infon>
      <offset>66406</offset>
      <text>We describe a novel molecular cascade that participates in the inflammatory skin response to excessive UV exposure and that is likely involved in the procarcinogenic role played by PPAR&#946;/&#948; in the murine skin exposed to UV. This cascade is of broader pathophysiological importance, since PPAR&#946;/&#948; and miR&#8208;21&#8208;3p levels are not only increased in murine and human skin exposed to UV, but also in human psoriatic skin and in human squamous cell carcinomas compared to healthy tissue. From a preclinical perspective, we identify miR&#8208;21&#8208;3p as an important target to explore for cutaneous anti&#8208;inflammatory treatment. Our data motivate the evaluation of topical delivery of miRNA as a valuable approach to explore to improve treatment of skin inflammatory disorders.</text>
    </passage>
    <passage>
      <infon key="type">title_1</infon>
      <offset>67178</offset>
      <text>Supporting information</text>
    </passage>
    <passage>
      <infon key="type">title</infon>
      <offset>67201</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="source">Genome Biol</infon>
      <infon key="volume">11</infon>
      <infon key="pub-id_pmid">20979621</infon>
      <infon key="fpage">R106</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>67212</offset>
      <text>Differential expression analysis for sequence count data</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="source">Curr Biol</infon>
      <infon key="lpage">1049</infon>
      <infon key="pub-id_pmid">16682203</infon>
      <infon key="fpage">1041</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>67269</offset>
      <text>The miRNA&#8208;processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles</text>
    </passage>
    <passage>
      <infon key="source">Genome Biol</infon>
      <infon key="volume">14</infon>
      <infon key="pub-id_pmid">24257477</infon>
      <infon key="fpage">R126</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>67374</offset>
      <text>Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors</text>
    </passage>
    <passage>
      <infon key="volume">43</infon>
      <infon key="source">Physiol Genomics</infon>
      <infon key="lpage">556</infon>
      <infon key="pub-id_pmid">20959495</infon>
      <infon key="fpage">543</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>67490</offset>
      <text>MicroRNAs in skin and wound healing</text>
    </passage>
    <passage>
      <infon key="volume">124</infon>
      <infon key="source">J Clin Investig</infon>
      <infon key="lpage">2146</infon>
      <infon key="pub-id_pmid">24743145</infon>
      <infon key="fpage">2136</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>67526</offset>
      <text>Cardiac fibroblast&#8208;derived microRNA passenger strand&#8208;enriched exosomes mediate cardiomyocyte hypertrophy</text>
    </passage>
    <passage>
      <infon key="volume">211</infon>
      <infon key="source">J Pathol</infon>
      <infon key="lpage">251</infon>
      <infon key="pub-id_pmid">17200942</infon>
      <infon key="fpage">241</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>67635</offset>
      <text>Skin ageing and its treatment</text>
    </passage>
    <passage>
      <infon key="volume">57</infon>
      <infon key="lpage">300</infon>
      <infon key="source">J R Stat Soc Series B</infon>
      <infon key="fpage">289</infon>
      <infon key="year">1995</infon>
      <infon key="type">ref</infon>
      <offset>67665</offset>
      <text>Controlling the false discovery rate: a practical and powerful approach to multiple testing</text>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="source">Cell Cycle</infon>
      <infon key="lpage">2193</infon>
      <infon key="pub-id_pmid">24067364</infon>
      <infon key="fpage">2183</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>67757</offset>
      <text>Tumor suppressor function of miR&#8208;483&#8208;3p on squamous cell carcinomas due to its pro&#8208;apoptotic properties</text>
    </passage>
    <passage>
      <infon key="volume">109</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">17116</infon>
      <infon key="pub-id_pmid">23027968</infon>
      <infon key="fpage">17111</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>67867</offset>
      <text>Solar UV radiation reduces the barrier function of human skin</text>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="lpage">197</infon>
      <infon key="pub-id_pmid">10652273</infon>
      <infon key="fpage">187</infon>
      <infon key="year">2000</infon>
      <infon key="type">ref</infon>
      <offset>67929</offset>
      <text>A mechanism of suppression of TGF&#8208;beta/SMAD signaling by NF&#8208;kappa B/RelA</text>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="source">Exp Dermatol</infon>
      <infon key="lpage">428</infon>
      <infon key="pub-id_pmid">23711067</infon>
      <infon key="fpage">426</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>68006</offset>
      <text>MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="source">Exp Dermatol</infon>
      <infon key="lpage">984</infon>
      <infon key="pub-id_pmid">19645824</infon>
      <infon key="fpage">979</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>68120</offset>
      <text>Extraction of high&#8208;quality epidermal RNA after ammonium thiocyanate&#8208;induced dermo&#8208;epidermal separation of 4&#160;mm human skin biopsies</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Cancer Cell</infon>
      <infon key="lpage">648</infon>
      <infon key="pub-id_pmid">22094257</infon>
      <infon key="fpage">635</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>68258</offset>
      <text>Targeting of the tumor suppressor GRHL3 by a miR&#8208;21&#8208;dependent proto&#8208;oncogenic network results in PTEN loss and tumorigenesis</text>
    </passage>
    <passage>
      <infon key="volume">454</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">61</infon>
      <infon key="pub-id_pmid">18548003</infon>
      <infon key="fpage">56</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>68389</offset>
      <text>SMAD proteins control DROSHA&#8208;mediated microRNA maturation</text>
    </passage>
    <passage>
      <infon key="volume">135</infon>
      <infon key="source">J Neurochem</infon>
      <infon key="lpage">146</infon>
      <infon key="pub-id_pmid">26119485</infon>
      <infon key="fpage">139</infon>
      <infon key="year">2015</infon>
      <infon key="type">ref</infon>
      <offset>68449</offset>
      <text>Mutual induction of transcription factor PPARgamma and microRNAs miR&#8208;145 and miR&#8208;329</text>
    </passage>
    <passage>
      <infon key="volume">39</infon>
      <infon key="source">Lipids</infon>
      <infon key="lpage">1099</infon>
      <infon key="pub-id_pmid">15726824</infon>
      <infon key="fpage">1093</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>68538</offset>
      <text>Functions of peroxisome proliferator&#8208;activated receptors (PPAR) in skin homeostasis</text>
    </passage>
    <passage>
      <infon key="volume">130</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="lpage">2689</infon>
      <infon key="pub-id_pmid">20574436</infon>
      <infon key="fpage">2686</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>68624</offset>
      <text>Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation</text>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="lpage">812</infon>
      <infon key="pub-id_pmid">23727859</infon>
      <infon key="fpage">808</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>68720</offset>
      <text>High&#8208;density genotyping study identifies four new susceptibility loci for atopic dermatitis</text>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="source">Prog Lipid Res</infon>
      <infon key="lpage">159</infon>
      <infon key="pub-id_pmid">16476485</infon>
      <infon key="fpage">120</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>68814</offset>
      <text>From molecular action to physiological outputs: peroxisome proliferator&#8208;activated receptors are nuclear receptors at the crossroads of key cellular functions</text>
    </passage>
    <passage>
      <infon key="volume">123</infon>
      <infon key="source">J Clin Investig</infon>
      <infon key="lpage">2575</infon>
      <infon key="pub-id_pmid">23676496</infon>
      <infon key="fpage">2564</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>68974</offset>
      <text>Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism</text>
    </passage>
    <passage>
      <infon key="volume">35</infon>
      <infon key="source">Carcinogenesis</infon>
      <infon key="lpage">1120</infon>
      <infon key="pub-id_pmid">24374827</infon>
      <infon key="fpage">1110</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>69055</offset>
      <text>miR&#8208;193b/365a cluster controls progression of epidermal squamous cell carcinoma</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="source">Nat Cell Biol</infon>
      <infon key="lpage">121</infon>
      <infon key="pub-id_pmid">26619149</infon>
      <infon key="fpage">111</infon>
      <infon key="year">2015</infon>
      <infon key="type">ref</infon>
      <offset>69137</offset>
      <text>Strand&#8208;specific in&#160;vivo screen of cancer&#8208;associated miRNAs unveils a role for miR&#8208;21 in SCC progression</text>
    </passage>
    <passage>
      <infon key="source">Genome Biol</infon>
      <infon key="volume">5</infon>
      <infon key="pub-id_pmid">15461798</infon>
      <infon key="fpage">R80</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>69248</offset>
      <text>Bioconductor: open software development for computational biology and bioinformatics</text>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="source">Carcinogenesis</infon>
      <infon key="lpage">14</infon>
      <infon key="pub-id_pmid">17893229</infon>
      <infon key="fpage">9</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>69333</offset>
      <text>Context&#8208;dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis</text>
    </passage>
    <passage>
      <infon key="volume">107</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">14344</infon>
      <infon key="pub-id_pmid">20651252</infon>
      <infon key="fpage">14339</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>69449</offset>
      <text>Identification of a microRNA signature of renal ischemia reperfusion injury</text>
    </passage>
    <passage>
      <infon key="volume">6</infon>
      <infon key="source">Sci Transl Med</infon>
      <infon key="type">ref</infon>
      <infon key="fpage">225re221</infon>
      <infon key="year">2014</infon>
      <offset>69525</offset>
      <text>Targeting miR&#8208;21 to treat psoriasis</text>
    </passage>
    <passage>
      <infon key="volume">85</infon>
      <infon key="source">Photochem Photobiol</infon>
      <infon key="lpage">773</infon>
      <infon key="pub-id_pmid">19076309</infon>
      <infon key="fpage">765</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>69563</offset>
      <text>Differential expression profiles of microRNAs in NIH3T3 cells in response to UVB irradiation</text>
    </passage>
    <passage>
      <infon key="volume">444</infon>
      <infon key="source">Biochem J</infon>
      <infon key="lpage">38</infon>
      <infon key="pub-id_pmid">22335598</infon>
      <infon key="fpage">27</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>69656</offset>
      <text>Ligand&#8208;activated PPARdelta inhibits UVB&#8208;induced senescence of human keratinocytes via PTEN&#8208;mediated inhibition of superoxide production</text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="source">Int J Biol Sci</infon>
      <infon key="lpage">235</infon>
      <infon key="pub-id_pmid">22253566</infon>
      <infon key="fpage">228</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>69798</offset>
      <text>The pro&#8208;inflammatory role of TGFbeta1: a paradox?</text>
    </passage>
    <passage>
      <infon key="volume">136</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="lpage">371</infon>
      <infon key="pub-id_pmid">26802234</infon>
      <infon key="fpage">365</infon>
      <infon key="year">2016</infon>
      <infon key="type">ref</infon>
      <offset>69850</offset>
      <text>microRNAs in Psoriasis</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="source">Nat Clin Pract Endocrinol Metab</infon>
      <infon key="lpage">657</infon>
      <infon key="pub-id_pmid">18957956</infon>
      <infon key="fpage">656</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>69873</offset>
      <text>Does vitamin D3 dosing schedule influence treatment efficacy in nursing home residents with vitamin D deficiency?</text>
    </passage>
    <passage>
      <infon key="volume">13</infon>
      <infon key="source">Photodermatol Photoimmunol Photomed</infon>
      <infon key="lpage">128</infon>
      <infon key="pub-id_pmid">9453079</infon>
      <infon key="fpage">117</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>69987</offset>
      <text>Structural and biochemical basis for the UVB&#8208;induced alterations in epidermal barrier function</text>
    </passage>
    <passage>
      <infon key="volume">65</infon>
      <infon key="source">Exp Toxicol Pathol</infon>
      <infon key="lpage">1148</infon>
      <infon key="pub-id_pmid">23891589</infon>
      <infon key="fpage">1145</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>70084</offset>
      <text>Induction of miR&#8208;21&#8208;PDCD4 signaling by UVB in JB6 cells involves ROS&#8208;mediated MAPK pathways</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="source">Nat Protoc</infon>
      <infon key="lpage">57</infon>
      <infon key="pub-id_pmid">19131956</infon>
      <infon key="fpage">44</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>70182</offset>
      <text>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Hum Mol Genet</infon>
      <infon key="lpage">4040</infon>
      <infon key="pub-id_pmid">21807764</infon>
      <infon key="fpage">4025</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>70275</offset>
      <text>Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome</text>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="source">Nat Rev Cancer</infon>
      <infon key="lpage">864</infon>
      <infon key="pub-id_pmid">22113163</infon>
      <infon key="fpage">849</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>70373</offset>
      <text>Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy</text>
    </passage>
    <passage>
      <infon key="volume">102</infon>
      <infon key="source">Circ Res</infon>
      <infon key="lpage">200</infon>
      <infon key="pub-id_pmid">18007025</infon>
      <infon key="fpage">193</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>70499</offset>
      <text>Transforming growth factor&#8208;beta1 is a molecular target for the peroxisome proliferator&#8208;activated receptor delta</text>
    </passage>
    <passage>
      <infon key="volume">100</infon>
      <infon key="source">Life Sci</infon>
      <infon key="lpage">54</infon>
      <infon key="pub-id_pmid">24530874</infon>
      <infon key="fpage">45</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>70615</offset>
      <text>Panduratin A, an activator of PPAR&#8208;alpha/delta, suppresses the development of oxazolone&#8208;induced atopic dermatitis&#8208;like symptoms in hairless mice</text>
    </passage>
    <passage>
      <infon key="source">Fitzpatrick's Dermatology in General Medicine</infon>
      <infon key="name_0">surname:Wolff;given-names:K</infon>
      <infon key="name_1">surname:Katz;given-names:S</infon>
      <infon key="type">ref</infon>
      <infon key="year">2008</infon>
      <offset>70766</offset>
      <text></text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="source">RNA Biol</infon>
      <infon key="lpage">713</infon>
      <infon key="pub-id_pmid">21712654</infon>
      <infon key="fpage">706</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>70767</offset>
      <text>Regulation and function of miRNA&#8208;21 in health and disease</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="source">EMBO J</infon>
      <infon key="lpage">2263</infon>
      <infon key="pub-id_pmid">23860128</infon>
      <infon key="fpage">2248</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>70827</offset>
      <text>A miR&#8208;34a&#8208;SIRT6 axis in the squamous cell differentiation network</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="source">EMBO J</infon>
      <infon key="lpage">1781</infon>
      <infon key="pub-id_pmid">15057277</infon>
      <infon key="fpage">1770</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>70897</offset>
      <text>Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis&#8208;like skin disorder</text>
    </passage>
    <passage>
      <infon key="volume">125</infon>
      <infon key="source">J Clin Investig</infon>
      <infon key="lpage">3026</infon>
      <infon key="pub-id_pmid">26121747</infon>
      <infon key="fpage">3008</infon>
      <infon key="year">2015</infon>
      <infon key="type">ref</infon>
      <offset>70996</offset>
      <text>MicroRNA&#8208;132 enhances transition from inflammation to proliferation during wound healing</text>
    </passage>
    <passage>
      <infon key="volume">108</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">10149</infon>
      <infon key="pub-id_pmid">21646541</infon>
      <infon key="fpage">10144</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>71087</offset>
      <text>Loss of the miR&#8208;21 allele elevates the expression of its target genes and reduces tumorigenesis</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Crit Rev Eukaryot Gene Expr</infon>
      <infon key="lpage">148</infon>
      <infon key="pub-id_pmid">21133843</infon>
      <infon key="fpage">141</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>71185</offset>
      <text>miRNA*: a passenger stranded in RNA&#8208;induced silencing complex?</text>
    </passage>
    <passage>
      <infon key="volume">128</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="lpage">377</infon>
      <infon key="pub-id_pmid">17713572</infon>
      <infon key="fpage">370</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>71250</offset>
      <text>Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation</text>
    </passage>
    <passage>
      <infon key="volume">195</infon>
      <infon key="source">Toxicol Appl Pharmacol</infon>
      <infon key="lpage">308</infon>
      <infon key="pub-id_pmid">15020192</infon>
      <infon key="fpage">298</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>71387</offset>
      <text>Toxic effects of ultraviolet radiation on the skin</text>
    </passage>
    <passage>
      <infon key="volume">467</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">90</infon>
      <infon key="pub-id_pmid">20693987</infon>
      <infon key="fpage">86</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>71438</offset>
      <text>OncomiR addiction in an in&#160;vivo model of microRNA&#8208;21&#8208;induced pre&#8208;B&#8208;cell lymphoma</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="source">Genome Res</infon>
      <infon key="lpage">45</infon>
      <infon key="pub-id_pmid">23034410</infon>
      <infon key="fpage">34</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>71528</offset>
      <text>Birth and expression evolution of mammalian microRNA genes</text>
    </passage>
    <passage>
      <infon key="volume">154</infon>
      <infon key="source">J Cell Biol</infon>
      <infon key="lpage">814</infon>
      <infon key="pub-id_pmid">11514592</infon>
      <infon key="fpage">799</infon>
      <infon key="year">2001</infon>
      <infon key="type">ref</infon>
      <offset>71587</offset>
      <text>Impaired skin wound healing in peroxisome proliferator&#8208;activated receptor (PPAR)alpha and PPARbeta mutant mice</text>
    </passage>
    <passage>
      <infon key="volume">1302</infon>
      <infon key="lpage">52</infon>
      <infon key="source">Int Congr Ser</infon>
      <infon key="fpage">45</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>71700</offset>
      <text>Roles of the peroxisome proliferators&#8208;activated receptor (PPAR) alpha and beta/delta in skin wound healing</text>
    </passage>
    <passage>
      <infon key="volume">6</infon>
      <infon key="source">EMBO Mol Med</infon>
      <infon key="lpage">98</infon>
      <infon key="pub-id_pmid">24203162</infon>
      <infon key="fpage">80</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>71809</offset>
      <text>Src is activated by the nuclear receptor peroxisome proliferator&#8208;activated receptor beta/delta in ultraviolet radiation&#8208;induced skin cancer</text>
    </passage>
    <passage>
      <infon key="volume">389</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">635</infon>
      <infon key="pub-id_pmid">9335507</infon>
      <infon key="fpage">631</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>71953</offset>
      <text>Identification of Smad7, a TGFbeta&#8208;inducible antagonist of TGF&#8208;beta signalling</text>
    </passage>
    <passage>
      <infon key="volume">49</infon>
      <infon key="source">Int J Dermatol</infon>
      <infon key="lpage">986</infon>
      <infon key="pub-id_pmid">20883261</infon>
      <infon key="fpage">978</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>72036</offset>
      <text>Ultraviolet radiation and skin cancer</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="source">Carcinogenesis</infon>
      <infon key="lpage">1844</infon>
      <infon key="pub-id_pmid">10469632</infon>
      <infon key="fpage">1837</infon>
      <infon key="year">1999</infon>
      <infon key="type">ref</infon>
      <offset>72074</offset>
      <text>A multihit, multistage model of chemical carcinogenesis</text>
    </passage>
    <passage>
      <infon key="source">PLoS One</infon>
      <infon key="volume">6</infon>
      <infon key="pub-id_pmid">21966511</infon>
      <infon key="fpage">e25377</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>72130</offset>
      <text>Angiopoietin&#8208;like 4 regulates epidermal differentiation</text>
    </passage>
    <passage>
      <infon key="volume">1843</infon>
      <infon key="source">Biochim Biophys Acta</infon>
      <infon key="lpage">1236</infon>
      <infon key="pub-id_pmid">24631504</infon>
      <infon key="fpage">1225</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>72188</offset>
      <text>Peroxisome proliferator&#8208;activated receptor gamma&#8208;mediated induction of microRNA&#8208;145 opposes tumor phenotype in colorectal cancer</text>
    </passage>
    <passage>
      <infon key="volume">41</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="lpage">W173</infon>
      <infon key="pub-id_pmid">23680784</infon>
      <infon key="fpage">W169</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>72323</offset>
      <text>DIANA&#8208;microT web server v5.0: service integration into miRNA functional analysis workflows</text>
    </passage>
    <passage>
      <infon key="volume">287</infon>
      <infon key="source">The Journal of biological chemistry</infon>
      <infon key="lpage">29335</infon>
      <infon key="pub-id_pmid">22773832</infon>
      <infon key="fpage">29324</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>72416</offset>
      <text>Induction of specific microRNAs inhibits cutaneous wound healing</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="source">Exp Dermatol</infon>
      <infon key="lpage">36</infon>
      <infon key="pub-id_pmid">17181634</infon>
      <infon key="fpage">28</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>72481</offset>
      <text>Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications</text>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="source">EMBO J</infon>
      <infon key="lpage">2099</infon>
      <infon key="pub-id_pmid">19536137</infon>
      <infon key="fpage">2090</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>72587</offset>
      <text>MicroRNA&#8208;mediated gene silencing modulates the UV&#8208;induced DNA&#8208;damage response</text>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="source">RNA</infon>
      <infon key="lpage">501</infon>
      <infon key="pub-id_pmid">19176604</infon>
      <infon key="fpage">493</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>72671</offset>
      <text>Impact of normalization on miRNA microarray expression profiling</text>
    </passage>
    <passage>
      <infon key="volume">276</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">26356</infon>
      <infon key="pub-id_pmid">11320083</infon>
      <infon key="fpage">26349</infon>
      <infon key="year">2001</infon>
      <infon key="type">ref</infon>
      <offset>72736</offset>
      <text>Ultraviolet irradiation blocks cellular responses to transforming growth factor&#8208;beta by down&#8208;regulating its type&#8208;II receptor and inducing Smad7</text>
    </passage>
    <passage>
      <infon key="volume">35</infon>
      <infon key="source">Carcinogenesis</infon>
      <infon key="lpage">966</infon>
      <infon key="pub-id_pmid">24363069</infon>
      <infon key="fpage">959</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>72886</offset>
      <text>Tumor&#8208;promoting role of TGFbeta1 signaling in ultraviolet B&#8208;induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells</text>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="source">Bioinformatics</infon>
      <infon key="lpage">776</infon>
      <infon key="pub-id_pmid">22285563</infon>
      <infon key="fpage">771</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>73071</offset>
      <text>Functional microRNA targets in protein coding sequences</text>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="lpage">6833</infon>
      <infon key="pub-id_pmid">22505577</infon>
      <infon key="fpage">6821</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>73127</offset>
      <text>A novel source for miR&#8208;21 expression through the alternative polyadenylation of VMP1 gene transcripts</text>
    </passage>
    <passage>
      <infon key="source">PLoS One</infon>
      <infon key="volume">5</infon>
      <infon key="pub-id_pmid">20300524</infon>
      <infon key="fpage">e9701</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>73231</offset>
      <text>Activation of PPARbeta/delta causes a psoriasis&#8208;like skin disease in&#160;vivo </text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="lpage">135</infon>
      <infon key="source">Dermatoendocrinology</infon>
      <infon key="fpage">130</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>73309</offset>
      <text>Peroxisome proliferator&#8208;activated receptors (PPARs) in dermatology: challenge and promise</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="source">Mol Cell Biol</infon>
      <infon key="lpage">4247</infon>
      <infon key="pub-id_pmid">17438130</infon>
      <infon key="fpage">4238</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>73401</offset>
      <text>Peroxisome proliferator&#8208;activated receptor alpha regulates a microRNA&#8208;mediated signaling cascade responsible for hepatocellular proliferation</text>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="source">Stat Appl Genet Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="fpage">3</infon>
      <infon key="year">2004</infon>
      <offset>73547</offset>
      <text>Linear models and empirical Bayes methods for assessing differential expression in microarray experiments</text>
    </passage>
    <passage>
      <infon key="volume">58</infon>
      <infon key="source">Hepatology</infon>
      <infon key="lpage">1692</infon>
      <infon key="pub-id_pmid">23703729</infon>
      <infon key="fpage">1681</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>73653</offset>
      <text>Epigenetic regulation of MicroRNA&#8208;122 by peroxisome proliferator activated receptor&#8208;gamma and hepatitis b virus X protein in hepatocellular carcinoma cells</text>
    </passage>
    <passage>
      <infon key="source">Oncogenesis</infon>
      <infon key="volume">1</infon>
      <infon key="pub-id_pmid">23552555</infon>
      <infon key="fpage">e3</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>73813</offset>
      <text>MicroRNA&#8208;203 functions as a tumor suppressor in basal cell carcinoma</text>
    </passage>
    <passage>
      <infon key="volume">275</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">29317</infon>
      <infon key="pub-id_pmid">10887185</infon>
      <infon key="fpage">29308</infon>
      <infon key="year">2000</infon>
      <infon key="type">ref</infon>
      <offset>73884</offset>
      <text>Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF&#8208;beta)&#8208;induced activation of Smad7. THE TGF&#8208;beta response element of the promoter requires functional Smad binding element and E&#8208;box sequences for transcriptional regulation</text>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="lpage">3277</infon>
      <infon key="pub-id_pmid">11751632</infon>
      <infon key="fpage">3263</infon>
      <infon key="year">2001</infon>
      <infon key="type">ref</infon>
      <offset>74146</offset>
      <text>Critical roles of PPAR beta/delta in keratinocyte response to inflammation</text>
    </passage>
    <passage>
      <infon key="volume">280</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">18170</infon>
      <infon key="pub-id_pmid">15708854</infon>
      <infon key="fpage">18163</infon>
      <infon key="year">2005</infon>
      <infon key="type">ref</infon>
      <offset>74221</offset>
      <text>Genetic&#8208; or transforming growth factor&#8208;beta 1&#8208;induced changes in epidermal peroxisome proliferator&#8208;activated receptor beta/delta expression dictate wound repair kinetics</text>
    </passage>
    <passage>
      <infon key="volume">41</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="lpage">W168</infon>
      <infon key="pub-id_pmid">23716633</infon>
      <infon key="fpage">W165</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>74399</offset>
      <text>miRmap web: comprehensive microRNA target prediction online</text>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="lpage">D229</infon>
      <infon key="pub-id_pmid">22135297</infon>
      <infon key="fpage">D222</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>74459</offset>
      <text>TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support</text>
    </passage>
    <passage>
      <infon key="volume">46</infon>
      <infon key="source">Physiol Genomics</infon>
      <infon key="lpage">122</infon>
      <infon key="pub-id_pmid">24326350</infon>
      <infon key="fpage">113</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>74548</offset>
      <text>MicroRNAs in normal and psoriatic skin</text>
    </passage>
    <passage>
      <infon key="volume">287</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">29908</infon>
      <infon key="pub-id_pmid">22782903</infon>
      <infon key="fpage">29899</infon>
      <infon key="year">2012</infon>
      <infon key="type">ref</infon>
      <offset>74587</offset>
      <text>MicroRNA&#8208;125b down&#8208;regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion</text>
    </passage>
    <passage>
      <infon key="volume">190</infon>
      <infon key="source">J Immunol</infon>
      <infon key="lpage">688</infon>
      <infon key="pub-id_pmid">23233723</infon>
      <infon key="fpage">678</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <offset>74738</offset>
      <text>MicroRNA&#8208;31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40</text>
    </passage>
    <passage>
      <infon key="volume">128</infon>
      <infon key="source">J&#160;Invest Dermatol</infon>
      <infon key="lpage">1949</infon>
      <infon key="pub-id_pmid">18305567</infon>
      <infon key="fpage">1940</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>74901</offset>
      <text>PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells</text>
    </passage>
    <passage>
      <infon key="volume">291</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="lpage">292</infon>
      <infon key="pub-id_pmid">26555259</infon>
      <infon key="fpage">382</infon>
      <infon key="year">2015</infon>
      <infon key="type">ref</infon>
      <offset>74973</offset>
      <text>Smad7 interacts with R&#8208;Smads to inhibit TGF&#8208;beta/Smad signaling</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="source">Int J Biol Sci</infon>
      <infon key="lpage">690</infon>
      <infon key="pub-id_pmid">21647251</infon>
      <infon key="fpage">685</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>75041</offset>
      <text>miR&#8208;21 promotes keratinocyte migration and re&#8208;epithelialization during wound healing</text>
    </passage>
    <passage>
      <infon key="volume">38</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="lpage">362</infon>
      <infon key="pub-id_pmid">16462742</infon>
      <infon key="fpage">356</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>75130</offset>
      <text>Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs</text>
    </passage>
    <passage>
      <infon key="volume">452</infon>
      <infon key="source">Nature</infon>
      <infon key="lpage">229</infon>
      <infon key="pub-id_pmid">18311128</infon>
      <infon key="fpage">225</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>75219</offset>
      <text>A skin microRNA promotes differentiation by repressing &#8216;stemness&#8217;</text>
    </passage>
    <passage>
      <infon key="volume">106</infon>
      <infon key="source">Proc Natl Acad Sci USA</infon>
      <infon key="lpage">502</infon>
      <infon key="pub-id_pmid">19114655</infon>
      <infon key="fpage">498</infon>
      <infon key="year">2009</infon>
      <infon key="type">ref</infon>
      <offset>75289</offset>
      <text>DGCR8&#8208;dependent microRNA biogenesis is essential for skin development</text>
    </passage>
    <passage>
      <infon key="volume">30</infon>
      <infon key="source">J Neurosci</infon>
      <infon key="lpage">6408</infon>
      <infon key="pub-id_pmid">20445066</infon>
      <infon key="fpage">6398</infon>
      <infon key="year">2010</infon>
      <infon key="type">ref</infon>
      <offset>75361</offset>
      <text>Peroxisome proliferator&#8208;activated receptor delta regulation of miR&#8208;15a in ischemia&#8208;induced cerebral vascular endothelial injury</text>
    </passage>
    <passage>
      <infon key="volume">155</infon>
      <infon key="source">Endocrinology</infon>
      <infon key="lpage">2165</infon>
      <infon key="pub-id_pmid">24666251</infon>
      <infon key="fpage">2155</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <offset>75495</offset>
      <text>Expression profiling of PPARgamma&#8208;regulated microRNAs in human subcutaneous and visceral adipogenesis in both genders</text>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="source">J Am Soc Nephrol</infon>
      <infon key="lpage">1681</infon>
      <infon key="pub-id_pmid">21852586</infon>
      <infon key="fpage">1668</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>75615</offset>
      <text>Smad3&#8208;mediated upregulation of miR&#8208;21 promotes renal fibrosis</text>
    </passage>
  </document>
</collection>
